↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

1,426 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (-)-trans-delta-9-tetrahydrocannabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 2   (im) avonex®   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 3   (r) 3-(5-dimethylcarbamoyl-pent-1-enyl)-n-(2-hydroxy-1- methylethyl) benzamide   Pentaerythritol tetranitrate   D01721   -   -   1件:
13 
 4   0,5 mg fingolimod   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 5   0.25mg rpc1063   -   -   -   -   1件:
13 
 6   1 - andrographis paniculata p/st extract   -   -   -   -   1件:
13 
 7   1% steroid cream   -   -   -   -   1件:
13 
 8   1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1h-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone   -   -   -   -   1件:
13 
 9   1.0mg rpc1063   -   -   -   -   1件:
13 
 10   10 milligram (mg) fampridine-sr (4-aminopyridine, 4-ap)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 11   10000iu vitamin d   Vitamin d   -   -   -   1件:
13 
 12   11c-acetate   Acetate   -   -   -   3件:
13,
86,
88 
 13   11c-pib   -   -   -   -   1件:
13 
 14   13-pcv booster   -   -   -   -   1件:
13 
 15   13-valent pneumococcal conjugate vaccine (13-pcv)   -   -   -   -   1件:
13 
 16   15 mg fampridine-sr (4-aminopyridine, 4-ap)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 17   18f-dpa-714 and 18f-fdg   Fludeoxyglucose f-18   -   -   -   1件:
13 
 18   18f-fdg   Fludeoxyglucose f-18   -   -   -   7件:
6,
13,
46,
53,
84,
127,
300 
 19   19 nor vitamin d   Vitamin d   -   -   -   1件:
13 
 20   2 - excipients   -   -   -   -   1件:
13 
 21   2-cda   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 22   2-cda, 2-chloro-2’-deoxy-beta-d-adenosine   Adenosine   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 23   2-cda, 2-chloro-2’-deoxy-ß-d-adenosine   Adenosine   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 24   2-chloro-2'-deoxyadenosine, 2cda   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 25   2-chloro-2’-deoxyadenosine (2-cda)   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 26   20 mg fampridine-sr (4-aminopyridine, 4-ap)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 27   20 mg ga   -   -   -   -   1件:
13 
 28   200106 or emd 28162   -   -   -   -   1件:
13 
 29   20mg/0.5ml ga   -   -   -   -   1件:
13 
 30   20mg/0.5ml glatiramer acetate   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 31   23-ppv   -   -   -   -   1件:
13 
 32   23-valent pneumococcal polysaccharide vaccine   -   -   -   -   3件:
13,
46,
53 
 33   23-valent pneumococcal polysaccharide vaccine (23-ppv)   -   -   -   -   1件:
13 
 34   25oh-vitamin d   Vitamin d   -   -   -   1件:
13 
 35   2b3-201   -   -   -   -   1件:
13 
 36   2cda   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 37   3 mg melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 38   3,4-diaminopyridine   -   -   -   -   3件:
11,
12,
13 
 39   4-aminopyridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   2件:
3,
13 
 40   4-ap   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 41   4.5 mg naltrexone   Naltrexone   D02095, D05113   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 42   40 mg ga   -   -   -   -   2件:
2,
13 
 43   40 mg glatiramer acetate   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   2件:
2,
13 
 44   5 mg melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 45   5000iu vitamin d   Vitamin d   -   -   -   1件:
13 
 46   52069.00.01   -   -   -   -   1件:
13 
 47   9060x   -   -   -   -   2件:
13,
149 
 48   95% pure ecgc capsules 200mg   -   -   -   -   1件:
13 
 49   [11c]flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
13 
 50   [123i]clinde   -   -   -   -   2件:
6,
13 
 51   [14c]-rpc1063 solution (0.1 mg/ml) for oral administration   -   -   -   -   3件:
13,
96,
97 
 52   [18f] pbr06   -   -   -   -   2件:
6,
13 
 53   [18f]-feppa   -   -   -   -   2件:
6,
13 
 54   [18f]dpa-714   -   -   -   -   1件:
13 
 55   [18f]florbetapir and pet imaging   -   -   -   -   1件:
13 
 56   [c-11]methylreboxetine   -   -   -   -   1件:
13 
 57   [f-18]pbr06   -   -   -   -   1件:
13 
 58   [zr-89]oxine-labeled leukocytes pet/mr   Oxyquinoline   D05321   -   -   1件:
13 
 59   A4i antagonist   -   -   -   -   1件:
13 
 60   Ab1010   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 61   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 62   Abobotulinumtoxin a   -   -   -   -   1件:
13 
 63   Abr-215062 sodium salt   -   -   -   -   2件:
13,
96 
 64   Abt-555   -   -   -   -   1件:
13 
 65   Abt-874/human monoclonal antibody against il-12   -   -   -   -   1件:
13 
 66   Abx-1431 hcl   -   -   -   -   1件:
13 
 67   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 68   Acetaminophen tab 650mg   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 69   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 70   Acetazolamide   Acetazolamide   D00218, D01196   13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9   7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation   6件:
13,
90,
115,
155,
225,
230 
 71   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 72   Acetylsalicylic acid   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   3件:
13,
46,
51 
 73   Acetylsalicylic acid at 1st visit,   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 74   Aclasta   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   3件:
13,
271,
274 
 75   Aclasta 5 mg infusionslösung   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 76   Aclasta 5mg solution for infusion   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 77   Act-128800   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 78   Act-128800 dose 1   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 79   Act-128800 dose 2   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 80   Act-128800 dose 3   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 81   Acth   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
13,
66,
145,
193,
222 
 82   Acthar   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   6件:
2,
13,
46,
49,
50,
222 
 83   Acthar gel   -   -   -   -   4件:
13,
46,
49,
84 
 84   Acthar gel (acth)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13 
 85   Active comparator receiving extavia®   -   -   -   -   1件:
13 
 86   Active control   -   -   -   -   1件:
13 
 87   Actos (pioglitazone)   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
13 
 88   Acyclovir   Acyclovir   D00222   -   -   2件:
13,
28 
 89   Adderall xr   -   -   -   -   1件:
13 
 90   Adderall xr 10 mg   -   -   -   -   1件:
13 
 91   Adderall xr 5mg   -   -   -   -   1件:
13 
 92   Adenosine   Adenosine   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
13,
58,
65 
 93   Adrenocorticotropic hormone   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
13,
50,
84 
 94   Adrenocorticotropic hormone (acth) gel (h.p. acthar®)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13 
 95   Ads-5102   -   -   -   -   2件:
6,
13 
 96   Ads-5102, 137 mg   -   -   -   -   1件:
13 
 97   Ads-5102, 274 mg   -   -   -   -   1件:
13 
 98   Aert, (r)-baclofen   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 99   Agee cream   -   -   -   -   1件:
13 
 100   Aimspro   -   -   -   -   2件:
13,
51 
 101   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 102   Alanine   L-alanine   D00012   -   -   3件:
13,
298,
299 
 103   Albumin (human) 25%, united states pharmacopeia (usp)   -   -   -   -   2件:
13,
14 
 104   Albuterol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
12,
13,
86,
89,
113,
231,
256,
299 
 105   Alcohol   Ethanol   D00068, D02798, D04855, D06542   -   -   4件:
13,
58,
279,
298 
 106   Alemtuzumab   Alemtuzumab   D02802   -   -   13件:
13,
15,
19,
20,
46,
51,
60,
63,
65,
85,
96,
164,
284 
 107   Alemtuzumab (gz402673)   Alemtuzumab   D02802   -   -   1件:
13 
 108   Alemtuzumab 12 mg   Alemtuzumab   D02802   -   -   1件:
13 
 109   Alemtuzumab 24 mg   Alemtuzumab   D02802   -   -   1件:
13 
 110   Alemtuzumab gz402673   Alemtuzumab   D02802   -   -   1件:
13 
 111   Alemtuzumab immunotherapy   Alemtuzumab   D02802   -   -   1件:
13 
 112   Alemtuzumab injection [lemtrada]   Alemtuzumab   D02802   -   -   1件:
13 
 113   Alfuzosin   Alfuzosin   D01692, D07124   1件: ADRA1A   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
13 
 114   Alks 8700   -   -   -   -   1件:
13 
 115   Alks 8700 delayed release (dr)   -   -   -   -   1件:
13 
 116   Alks 8700 delayed release (dr) capsule   -   -   -   -   1件:
13 
 117   Allogeneic human umbilical cord tissue-derived mesenchymal stem cells   -   -   -   -   1件:
13 
 118   Alpha lipoic acid   Lipoic acid   D00048, D00086   -   -   1件:
13 
 119   Alpha-lipoic acid   Lipoic acid   D00048, D00086   -   -   2件:
2,
13 
 120   Alpha1-antitrypsin   -   -   -   -   1件:
13 
 121   Altri farmaci del sistema nervoso   -   -   -   -   1件:
13 
 122   Amantadine   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   4件:
6,
8,
13,
127 
 123   American ginseng   Ginseng   D06772   -   -   1件:
13 
 124   American ginseng extract ht-1001   Ginseng   D06772   -   -   1件:
13 
 125   Amiloride   Amiloride   D00649, D07447   3件: SCNN1A, SCNN1B, SCNN1G   2件: Aldosterone-regulated sodium reabsorption, Taste transduction   3件:
13,
225,
299 
 126   Amiloride hydrochloride   Amiloride   D00649, D07447   3件: SCNN1A, SCNN1B, SCNN1G   2件: Aldosterone-regulated sodium reabsorption, Taste transduction   1件:
13 
 127   Amiloride hydrochloride, 2 h2o   Amiloride   D00649, D07447   3件: SCNN1A, SCNN1B, SCNN1G   2件: Aldosterone-regulated sodium reabsorption, Taste transduction   1件:
13 
 128   Amilostad hct   -   -   -   -   1件:
13 
 129   Amilostad hct tablets   -   -   -   -   1件:
13 
 130   Ampyra   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 131   An100226   -   -   -   -   2件:
13,
96 
 132   An100226, bg00002   -   -   -   -   1件:
13 
 133   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 134   Androgel 1 % topical gel   -   -   -   -   1件:
13 
 135   Androgel 100mg gel   -   -   -   -   1件:
13 
 136   Andrographolides   -   -   -   -   1件:
13 
 137   Anesthetic topical adhesive synera   -   -   -   -   1件:
13 
 138   Anti lp40 antibody, subclass igg4 la294   -   -   -   -   2件:
13,
46 
 139   Anti-cd25 humanized monoclonal antibody   -   -   -   -   1件:
13 
 140   Anti-cd52 monoclonal antibody   -   -   -   -   1件:
13 
 141   Anti-il-12   -   -   -   -   2件:
13,
96 
 142   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 143   Anticholinergic medication   -   -   -   -   1件:
13 
 144   Antihistamine   -   -   -   -   2件:
13,
46 
 145   Antimycotic   -   -   -   -   1件:
13 
 146   Antithymocyte   -   -   -   -   1件:
13 
 147   Antithymocyte immunoglobulin (rabbit)   Rabbit   -   -   -   2件:
13,
65 
 148   Arbaclofen   Arbaclofen   D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   2件:
13,
206 
 149   Arbaclofen er tablets   Arbaclofen   D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 150   Arbaclofen extended release tablets   Arbaclofen   D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 151   Arbaclofen placarbil   Arbaclofen placarbil   D08861   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 152   Arbaclofen placarbil 15 mg bid   Arbaclofen placarbil   D08861   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 153   Arbaclofen placarbil 30 mg bid   Arbaclofen placarbil   D08861   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 154   Arbaclofen placarbil 45 mg bid   Arbaclofen placarbil   D08861   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 155   Aricept   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
6,
13,
78,
124 
 156   Aricept 10 mg   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 157   Aricept 10 mg filmdragerade tabletter   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 158   Aricept 5 mg   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 159   Aricept 5 mg filmdragerade tabletter   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 160   Arm 1 - geh120714 (18f) injection   -   -   -   -   1件:
13 
 161   Armodafinil   Armodafinil   D03215   1件: SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   3件:
6,
13,
84 
 162   Arn-6039   -   -   -   -   1件:
13 
 163   Arzerra   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 164   Asb-683699   -   -   -   -   1件:
13 
 165   Aspartate   Aspartic acid   D00013   -   -   3件:
13,
75,
299 
 166   Aspirin   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231 
 167   Aspirin 650mg oral capsule   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 168   Ata188   -   -   -   -   1件:
13 
 169   Atacicept   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
49,
66 
 170   Atacicept 150 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 171   Atacicept 25 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
13,
66 
 172   Atacicept 75 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 173   Atl1102   Atl1102   -   -   -   1件:
13 
 174   Atomoxetine   Atomoxetine   D02574, D07473   1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13 
 175   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 176   Atx-ms-1467   -   -   -   -   1件:
13 
 177   Aubagio   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 178   Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 179   Aubagio®   -   -   -   -   1件:
13 
 180   Autologous adipose derived mesenchymal cells   -   -   -   -   1件:
13 
 181   Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved   -   -   -   -   1件:
13 
 182   Autologous bone marrow-derived mononuclear stem cells   -   -   -   -   1件:
13 
 183   Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope   -   -   -   -   1件:
13 
 184   Autologous hematopoietic stem cell   -   -   -   -   1件:
13 
 185   Autologous mesenchymal cell product   -   -   -   -   1件:
13 
 186   Autologous mesenchymal stem cell transplantation   -   -   -   -   1件:
13 
 187   Autologous mesenchymal stem cells   -   -   -   -   5件:
2,
6,
13,
17,
46 
 188   Autologous stem cells   -   -   -   -   2件:
13,
51 
 189   Autologous t-lymphocytes   -   -   -   -   1件:
13 
 190   Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3)   -   -   -   -   1件:
13 
 191   Av605   -   -   -   -   1件:
13 
 192   Avonex   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
13,
97 
 193   Avonex (interferon beta 1a)   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 194   Avonex (interferon beta-1a), biogen idec ltd   Human interferon beta   -   -   -   1件:
13 
 195   Avonex 30 µg/0,5 ml solution for injection   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 196   Avonex and topamax   -   -   -   -   1件:
13 
 197   Avonex im 4sir 30mcg/0,5ml 4ag   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 198   Avonex/betaseron/copaxone/rebif   -   -   -   -   1件:
13 
 199   Avonex/zocor   -   -   -   -   1件:
13 
 200   Avonex®   -   -   -   -   1件:
13 
 201   Avonex® monotherapy (6.0 miu administered i.m. each week)   -   -   -   -   1件:
13 
 202   Avp-923   -   -   -   -   3件:
2,
6,
13 
 203   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 204   Azatioprina   Azathioprine   D00238, D03033   -   -   3件:
13,
96,
97 
 205   Azatioprina hex. 50cpr 50mg bl   Azathioprine   D00238, D03033   -   -   1件:
13 
 206   Azithromycin   Azithromycin   D02134, D06390, D07486   -   -   6件:
13,
84,
85,
96,
228,
299 
 207   Bacille calmette-guerin vaccine   -   -   -   -   1件:
13 
 208   Bacille of calmette-guerin   -   -   -   -   1件:
13 
 209   Baclofen   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   5件:
2,
10,
13,
18,
149 
 210   Baclofen 20 mg   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 211   Baclofen ir   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 212   Baf312   -   -   -   -   2件:
13,
50 
 213   Baf312 0,25 mg tablet   -   -   -   -   1件:
13 
 214   Baf312 1 mg tablet   -   -   -   -   2件:
13,
50 
 215   Baf312 4 mg tablet   -   -   -   -   1件:
13 
 216   Baf312 hemifumarate   -   -   -   -   2件:
13,
50 
 217   Baf312a   -   -   -   -   1件:
13 
 218   Bafiertam   -   -   -   -   1件:
13 
 219   Balance   Isoxaflutole   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299 
 220   Baminercept   Baminercept   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97 
 221   Baseline treatment   -   -   -   -   1件:
13 
 222   Bat4406f   -   -   -   -   1件:
13 
 223   Bay 79-4998   -   -   -   -   1件:
13 
 224   Bay86-5046   -   -   -   -   1件:
13 
 225   Bay86-5046_interferon-beta-1b   -   -   -   -   1件:
13 
 226   Bazedoxifene   Bazedoxifene   D03062   -   -   1件:
13 
 227   Bazedoxifene acetate   Bazedoxifene   D03062   -   -   1件:
13 
 228   Bbr 2778   -   -   -   -   2件:
11,
13 
 229   Bcd-033 (interferon beta 1a)   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 230   Bcd-054 180 mcg   -   -   -   -   1件:
13 
 231   Bcd-054 240 mcg   -   -   -   -   1件:
13 
 232   Bcd-063   -   -   -   -   1件:
13 
 233   Bcd-132   -   -   -   -   1件:
13 
 234   Bcg20-0134   -   -   -   -   1件:
13 
 235   Beam   Tricyclazole   -   -   -   1件:
13 
 236   Beam regimen   Tricyclazole   -   -   -   1件:
13 
 237   Beetainterferoni -1a   -   -   -   -   1件:
13 
 238   Best available therapy (bat)   -   -   -   -   1件:
13 
 239   Beta interferon   Human interferon beta   -   -   -   1件:
13 
 240   Beta-1b interferoni   -   -   -   -   1件:
13 
 241   Beta-alanine   L-alanine   D00012   -   -   1件:
13 
 242   Beta-alanine supplementation   L-alanine   D00012   -   -   1件:
13 
 243   Beta-carotene   Beta carotene   D03101   -   -   1件:
13 
 244   Beta-interferon   Human interferon beta   -   -   -   1件:
13 
 245   Betacarotene   Beta carotene   D03101   -   -   1件:
13 
 246   Betaferon   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 247   Betaferon 250 microgram/ml   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 248   Betaferon 250 microgram/ml, powder and solvent for solution for injection   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 249   Betaferon 250µg   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 250   Betaferon 500mcg   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 251   Betaferon 500µg   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 252   Betaferon sc 15f 0,25mg 15sir   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 253   Betaferon*15confez 0,25mg/ml+   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 254   Betaferon, bay 86-5046   -   -   -   -   1件:
13 
 255   Betaferon/betaseron   -   -   -   -   1件:
13 
 256   Betaferon®   -   -   -   -   1件:
13 
 257   Betaferon® (interferon beta-1b)   Human interferon beta   -   -   -   1件:
13 
 258   Betaseron   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 259   Betaseron (interferon beta-1b, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 260   Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag   Human interferon beta   -   -   -   1件:
13 
 261   Betmiga   Mirabegron   D09535   1件: ADRB3   7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway   1件:
13 
 262   Bevacizumab   Bevacizumab   D06409   1件: VEGFA   21件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway   9件:
13,
34,
85,
86,
87,
89,
227,
280,
331 
 263   Bexarotene   Bexarotene   D03106   3件: RXRA, RXRB, RXRG   15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease (NAFLD), Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer   2件:
13,
75 
 264   Bg00002   -   -   -   -   1件:
13 
 265   Bg00002 (natalizumab)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 266   Bg00002-e (natalizumab high titer)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 267   Bg00012   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   2件:
13,
46 
 268   Bg00012 (dmf)   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 269   Bg00012 (dmf) (tecfidera®.)   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 270   Bg0002 (natalizumab)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 271   Bg9418 (interferon beta 1-a)   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 272   Bg9418 (interferon beta-1a)   Human interferon beta   -   -   -   2件:
13,
97 
 273   Bgg492   -   -   -   -   1件:
13 
 274   Bht-3009   -   -   -   -   1件:
13 
 275   Bht-3009 0.5 mg   -   -   -   -   1件:
13 
 276   Bht-3009 1.5 mg   -   -   -   -   1件:
13 
 277   Bht-3009-01   -   -   -   -   1件:
13 
 278   Biib017   -   -   -   -   1件:
13 
 279   Biib017 (peginterferon beta-1a)   -   -   -   -   1件:
13 
 280   Biib019   -   -   -   -   1件:
13 
 281   Biib019 (daclizumab)   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 282   Biib033   -   -   -   -   1件:
13 
 283   Biib033 (anti-lingo)   -   -   -   -   1件:
13 
 284   Biib033 (opicinumab)   Opicinumab   -   -   -   1件:
13 
 285   Biib041   -   -   -   -   1件:
13 
 286   Biib041 (fampridine)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 287   Biib041 (fampridine-sr)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 288   Biib041 (pr fampridine)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 289   Biib061   -   -   -   -   1件:
13 
 290   Biotin   Biotin   D00029   -   -   3件:
2,
13,
20 
 291   Birt 2584 xx   -   -   -   -   1件:
13 
 292   Bisacodyl   Bisacodyl   D00245   -   -   1件:
13 
 293   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 294   Blood samples   -   -   -   -   8件:
13,
41,
46,
51,
61,
97,
227,
271 
 295   Blood sampling   -   -   -   -   4件:
13,
19,
51,
96 
 296   Bmmnc   -   -   -   -   2件:
13,
57 
 297   Bms 188667 (abatacept)   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   1件:
13 
 298   Bone marrow autologous mesenchymal stem cells transplantation   -   -   -   -   1件:
13 
 299   Borage oil   Borage oil   -   -   -   1件:
13 
 300   Borage oil 20% gla   Borage oil   -   -   -   1件:
13 
 301   Bosentan   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   9件:
13,
41,
47,
51,
84,
85,
86,
88,
210 
 302   Boswelan   -   -   -   -   1件:
13 
 303   Boswellia serrata   Indian frankincense   -   -   -   1件:
13 
 304   Boswellia serrata extract   Indian frankincense   -   -   -   1件:
13 
 305   Boswellia serrata extract ps0201bo capsules   Indian frankincense   -   -   -   1件:
13 
 306   Boswellic acids (boswelan)   -   -   -   -   1件:
13 
 307   Botox   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
6,
13,
149,
226 
 308   Botox®   -   -   -   -   1件:
13 
 309   Botulinum toxin a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
13,
51,
149,
226 
 310   Botulinum toxin a - haemagglutinin complex   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
13 
 311   Botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 312   Bx-1   -   -   -   -   1件:
13 
 313   C1-esterase inhibitor (cinryze)   -   -   -   -   1件:
13 
 314   C105   -   -   -   -   1件:
13 
 315   Calcio   Calcium   -   -   -   1件:
13 
 316   Calcio folinato dc.it   Calcium   -   -   -   1件:
13 
 317   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 318   Calcium carbonate   Calcium carbonate   D00932, D10802   -   -   7件:
13,
19,
46,
75,
96,
235,
299 
 319   Calcium levofolinate   Calcium   -   -   -   1件:
13 
 320   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 321   Cannabidiol / dronabinol capsule 5 mg+2,5 mg   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 322   Cannabidiol capsule 5 mg   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 323   Cannabis   Medical cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 324   Cannabis based medicine extract (sativex)   Medical cannabis   -   -   -   1件:
13 
 325   Cannabis, medical   Medical cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 326   Cannador   -   -   -   -   1件:
13 
 327   Caprylic triglyceride   Tricaprylin   -   -   -   1件:
13 
 328   Capsules with 160 mg teavigo (at least 94% egcg)   Epigallocatechin gallate   -   -   -   1件:
13 
 329   Carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   8件:
2,
4,
6,
13,
17,
90,
164,
201 
 330   Carbonate   Carbonate ion   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299 
 331   Carmustine   Carmustine   D00254   -   -   5件:
11,
13,
14,
28,
60 
 332   Carmustine, etoposide, cytarabine, and melphalan (beam)   Carmustine, Cytarabine   D00168, D00254, D03046, D03637   -   -   1件:
13 
 333   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 334   Carnosine   Carnosine   -   -   -   2件:
6,
13 
 335   Carnosine, capsulle, 2 g/day, 8 weeks   Carnosine   -   -   -   1件:
13 
 336   Cci-779   -   -   -   -   2件:
13,
46 
 337   Cdp323   Cdp323   -   -   -   1件:
13 
 338   Cellular therapy with ebv specific autologous ctl infusion   -   -   -   -   1件:
13 
 339   Ceralifimod   -   -   -   -   1件:
13 
 340   Ceralifmod   -   -   -   -   1件:
13 
 341   Cesamet™ (nabilone)   Nabilone   D05099   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 342   Ceterizine   -   -   -   -   1件:
13 
 343   Cetirizina   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 344   Cetirizina mylan generics   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 345   Cetirizine   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   2件:
13,
35 
 346   Cetirizine hydrochloride   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 347   Cgp 77116   -   -   -   -   1件:
13 
 348   Charcoal   Activated charcoal   D03251   -   -   1件:
13 
 349   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 350   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 351   Cholecalciferol, vitamin d3   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
13 
 352   Cholestyramine   Cholestyramine   -   -   -   2件:
13,
79 
 353   Chr-1103 / gbr500   -   -   -   -   1件:
13 
 354   Cianocobalamina   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   1件:
13 
 355   Cianocobalamina fu dc.it   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   1件:
13 
 356   Ciclofosfamide   Cyclophosphamide   D00287, D07760   -   -   1件:
13 
 357   Circadin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 358   Circadin ( inn= melatonin)   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 359   Cisapride   Cisapride   D00274, D02092   3件: HTR2A, HTR3A, HTR4   7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
13 
 360   Cladribine   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   2件:
13,
94 
 361   Cladribine 3.5 mg/kg   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 362   Cladribine 5.25 mg/kg   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 363   Cladribine tablets   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 364   Clemastine   Clemastine   D00666, D03535   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 365   Clostridium botulinum   Clostridium botulinum   -   -   -   1件:
13 
 366   Clostridium botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
13 
 367   Cnm-au8   -   -   -   -   2件:
2,
13 
 368   Cnp-ms-0601   -   -   -   -   1件:
13 
 369   Cnto 1275   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   2件:
13,
96 
 370   Co-14   -   -   -   -   1件:
13 
 371   Coconut   Coconut   -   -   -   1件:
13 
 372   Coconut oil   Coconut oil   D05326   -   -   1件:
13 
 373   Coconut oil and epigallocatechin gallate   Epigallocatechin gallate   -   -   -   1件:
13 
 374   Coenzyme q   -   -   -   -   1件:
13 
 375   Colecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   4件:
13,
46,
96,
228 
 376   Colecalciferol concentrate (oily form)   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
13 
 377   Control   Chloroxylenol   D03473   -   -   4件:
6,
13,
46,
168 
 378   Cop-1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 379   Cop-1/copolymer-1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 380   Copaxone   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 381   Copaxone 20 mg/ml   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 382   Copaxone 20 mg/ml solution for injection, pre-filled syringe   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 383   Copaxone 40 mg/ml solution for injection, pre-filled syringe   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 384   Copaxone subcutaneous injection syringe   -   -   -   -   1件:
13 
 385   Copaxone-teva   -   -   -   -   1件:
13 
 386   Copaxone®   -   -   -   -   1件:
13 
 387   Copolymer 1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 388   Copolymer-1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 389   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 390   Corticosteroids & tancart19/20   -   -   -   -   1件:
13 
 391   Corticotropin   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   7件:
2,
13,
46,
75,
78,
84,
222 
 392   Cranberry   Cranberry   -   -   -   1件:
13 
 393   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 394   Cs-0777 tablets   -   -   -   -   1件:
13 
 395   Curcumin   Curcumin   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299 
 396   Cyclophosfamide   -   -   -   -   1件:
13 
 397   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 398   Cyclophosphamide (drug)   Cyclophosphamide   D00287, D07760   -   -   1件:
13 
 399   Cyclophosphamide and atg   Cyclophosphamide   D00287, D07760   -   -   1件:
13 
 400   Cyclophosphamide monohydrate   Cyclophosphamide   D00287, D07760   -   -   2件:
13,
60 
 401   Cyclophosphamide/glatiramer acetate   Cyclophosphamide   D00287, D07760   -   -   1件:
13 
 402   Cymbalta   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49 
 403   Cysteine   L-cysteine   D00026, D02326   -   -   9件:
6,
13,
19,
84,
85,
88,
90,
254,
296 
 404   Cytarabine   Cytarabine   D00168, D03046, D03637   -   -   6件:
11,
13,
14,
25,
49,
60 
 405   Cytolytic cd4+ t cells   -   -   -   -   1件:
13 
 406   Células madre mesenquimales   -   -   -   -   1件:
13 
 407   D mannose   Mannose   -   -   -   1件:
13 
 408   D-aspartate   D-aspartic acid   -   -   -   1件:
13 
 409   D-biotin   Biotin   D00029   -   -   2件:
13,
20 
 410   Dac-hyp   -   -   -   -   1件:
13 
 411   Daclizumab   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   7件:
13,
56,
60,
65,
97,
283,
284 
 412   Daclizumab (anti-cd25 humanized monoclonal antibody)   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 413   Daclizumab high yield process   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 414   Daclizumab hyp   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 415   Daclizumab hyp (dac hyp)   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 416   Daclizumab with greek suufix   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 417   Dalfampridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   2件:
4,
13 
 418   Dalfampridine er   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 419   Dalfampridine-er 10mg   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 420   Dalfampridine-er 5mg   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 421   Darifenacin   Darifenacin   D01699, D03654   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   2件:
6,
13 
 422   Dc-tab   -   -   -   -   1件:
13 
 423   Dekristol   -   -   -   -   2件:
13,
97 
 424   Dekristol 20000 ie   -   -   -   -   1件:
13 
 425   Dekristol® 400-tabletten   -   -   -   -   1件:
13 
 426   Dekristol®-tablette 1 (400 ie)   -   -   -   -   1件:
13 
 427   Delta-9-tetrahydrocannabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 428   Demestril septem   -   -   -   -   1件:
13 
 429   Dexamethason   -   -   -   -   3件:
13,
46,
331 
 430   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 431   Dexamethasone soduim phosphate   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 432   Dexchlorpheniramine   Dexchlorpheniramine   D07803   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 433   Dexrazoxane   Dexrazoxane   D03730   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 434   Dexrazoxane (drz) plus mitoxantrone (mx)   Mitoxantrone   D02166, D08224   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 435   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 436   Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   2件:
2,
13 
 437   Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   2件:
2,
13 
 438   Dibase   -   -   -   -   1件:
13 
 439   Diclofenac   Diclofenac   D00903, D00904, D07816   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   4件:
13,
34,
46,
271 
 440   Diclofenac sodium topical gel   Diclofenac   D00903, D00904, D07816   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 441   Dimethyl fumarate   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   3件:
13,
51,
86 
 442   Dimethyl fumarate (dmf)   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   3件:
13,
51,
86 
 443   Dimethyl fumarate [dmf]   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 444   Dimetilfumarato   -   -   -   -   1件:
13 
 445   Diphenydramine   -   -   -   -   1件:
13 
 446   Diroximel fumarate   Diroximel fumarate   D11154   -   -   1件:
13 
 447   Diroximel fumarate (drf)   Diroximel fumarate   D11154   -   -   1件:
13 
 448   Dirucotide   Dirucotide   D09396   -   -   1件:
13 
 449   Dirucotide acetate   Dirucotide   D09396   -   -   1件:
13 
 450   Discontinuation of disease modifying therapy   -   -   -   -   1件:
13 
 451   Disease modifying therapy   -   -   -   -   1件:
13 
 452   Dmt continuation   -   -   -   -   1件:
13 
 453   Domperidone   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   5件:
6,
13,
17,
51,
230 
 454   Donepezil   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   9件:
5,
6,
13,
46,
78,
124,
127,
156,
206 
 455   Donepezil hci (drug)   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 456   Dotarem 0,5mmol/ml,   Gadoteric acid   D08007   -   -   1件:
13 
 457   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 458   Dpa-714 pet/mri   -   -   -   -   1件:
13 
 459   Dronabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   5件:
2,
13,
46,
271,
298 
 460   Dronabinol capsule 2,5 mg   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 461   Dtpa   Pentetic acid   D05422   -   -   3件:
13,
28,
299 
 462   Duloxetine   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
13 
 463   Duloxetine hydrochloride (hci)   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
13 
 464   Dydrogesterone   Dydrogesterone   D01217   1件: PGR   4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
13 
 465   Dysport   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   2件:
13,
36 
 466   Dysport®   -   -   -   -   1件:
13 
 467   Early highly effective therapies group   -   -   -   -   1件:
13 
 468   Ebixa   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
6,
13 
 469   Ecp002a   -   -   -   -   1件:
13 
 470   Eculizumab   Eculizumab   D03940   1件: C5   7件: Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   7件:
11,
13,
14,
62,
109,
222,
223 
 471   Efalizumab   Efalizumab   D03959   1件: ITGAL   11件: Cell adhesion molecules (CAMs), Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis   8件:
11,
13,
37,
46,
53,
61,
95,
96 
 472   Egb 761® (tanakan®)   Ginkgo biloba   -   -   -   1件:
13 
 473   Egcg   Epigallocatechin gallate   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299 
 474   Ek-12   -   -   -   -   1件:
13 
 475   Elezanumab   Elezanumab   D11355   1件: RGMA   2件: Axon guidance, TGF-beta signaling pathway   1件:
13 
 476   Elnd002   -   -   -   -   1件:
13 
 477   Emselex 15 mg retardtabletten   -   -   -   -   1件:
13 
 478   Emselex 7,5 mg retardtabletten   -   -   -   -   1件:
13 
 479   Ena713   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 480   Encapsulated simvastatin tablets   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 481   Endoxan   -   -   -   -   2件:
13,
28 
 482   Endoxan - ciclofosfamide   Cyclophosphamide   D00287, D07760   -   -   1件:
13 
 483   Endoxan baxter   -   -   -   -   1件:
13 
 484   Enriched hematopoetic stem cell infusion   -   -   -   -   3件:
13,
19,
284 
 485   Eparmefolin 30 cpr 0,1/0,5mg   -   -   -   -   1件:
13 
 486   Epigallocatechin   Epigallocatechin   -   -   -   4件:
13,
28,
85,
113 
 487   Epigallocatechin gallate   Epigallocatechin gallate   -   -   -   1件:
13 
 488   Epoetin alfa   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   2件:
13,
46 
 489   Epoetin beta   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
13 
 490   Erypo/erypo fs   -   -   -   -   1件:
13 
 491   Erythropoietin   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 492   Escalation therapies group   -   -   -   -   1件:
13 
 493   Escitalopram   Escitalopram   D02567, D07704, D07913   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
2,
6,
13 
 494   Escitalopram oxalate antidepressant   Escitalopram   D02567, D07704, D07913   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
13 
 495   Essential - hydroxytyrosol   Hydroxytyrosol   -   -   -   1件:
13 
 496   Essential fatty acids   -   -   -   -   1件:
13 
 497   Estradiol   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   5件:
13,
46,
49,
226,
299 
 498   Estradiol hemihydrate   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
13 
 499   Estriol   Estriol   D00185, D01986   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   2件:
13,
227 
 500   Estroprogestins   -   -   -   -   1件:
13 
 501   Eszopiclone   Eszopiclone   D02624   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   3件:
6,
13,
46 
 502   Ethinylestradiol   Ethinylestradiol   D00554   1件: ESR1   8件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
13 
 503   Etifoxine   Etifoxine   D07320   -   -   1件:
13 
 504   Etims   -   -   -   -   1件:
13 
 505   Etims (edc-fixed autologous pbmcs coupled with 7 immunodominant myelin peptides in ms patients)   -   -   -   -   1件:
13 
 506   Etoposide   Etoposide   D00125, D04107   2件: TOP2A, TOP2B   1件: Platinum drug resistance   11件:
11,
13,
14,
26,
28,
34,
60,
65,
85,
164,
331 
 507   Eu/1/08/454/001-002, eu/1/08/454/005-007   -   -   -   -   1件:
13 
 508   Eu/1/95/003/005-010   -   -   -   -   1件:
13 
 509   Eu/1/97/033/002   -   -   -   -   1件:
13 
 510   Eu/1/98/063/001-003   -   -   -   -   1件:
13 
 511   Eu/1/98/063/004-006   -   -   -   -   1件:
13 
 512   Evobrutinib   Evobrutinib   -   -   -   3件:
13,
46,
49 
 513   Exelon   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
13 
 514   Exelon transdermales pflaster   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 515   Experimental glatiramer acetate   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 516   Extavia   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 517   Extavia (interferon beta-1b), novartis pharma ag   Human interferon beta   -   -   -   1件:
13 
 518   Extavia 250 microgram/ml   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 519   Extavia 250 micrograms/ml   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 520   Extavia*sc 15fl 250mcg/ml+15si   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 521   Extavia®   -   -   -   -   1件:
13 
 522   Extended release fampridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 523   Extended-release oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 524   Extended-release quetiapine fumarate   Quetiapine   D00458, D08456   2件: DRD2, HTR2A   11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   1件:
13 
 525   F-18 fedaa1106 (bay85-8101)   -   -   -   -   1件:
13 
 526   Fampridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 527   Fampridine sr   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 528   Fampridine-sr   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 529   Fampridine-sr b.i.d. (twice daily)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 530   Fampyra   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 531   Fampyra 10 mg prolonged-release tablets   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 532   Fampyra 10mg prolonged release tablets   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 533   Febuxostat   Febuxostat   D01206   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   3件:
2,
6,
13 
 534   Fecal microbial transplant (fmt)   -   -   -   -   1件:
13 
 535   Fecal microbial transplants   -   -   -   -   1件:
13 
 536   Fecal microbiota   -   -   -   -   2件:
13,
97 
 537   Femoston 1/10   -   -   -   -   1件:
13 
 538   Femoston 2/10   -   -   -   -   1件:
13 
 539   Feraheme   Ferumoxytol   D04177   -   -   1件:
13 
 540   Ferumoxytol   Ferumoxytol   D04177   -   -   1件:
13 
 541   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 542   Fingolimob (fty)   -   -   -   -   1件:
13 
 543   Fingolimod   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   3件:
13,
14,
156 
 544   Fingolimod (fty720)   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   2件:
13,
156 
 545   Fingolimod 0.5 mg   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 546   Fingolimod 1.25 mg   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 547   Fingolimod hydrochloride   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 548   Fingolimodi   -   -   -   -   1件:
13 
 549   Fingolmod   -   -   -   -   1件:
13 
 550   Firategrast   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 551   Firategrast (usan approved name)   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 552   Firategrast 150 mg   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 553   Firategrast 300 mg   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 554   Firategrast gastro-retentive solution   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 555   Firategrast immediate release tablet   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 556   Firategrast modified release tablet   Firategrast   D06590   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 557   Fish oil   Fish oil   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299 
 558   Fish oil concentrate   Fish oil   -   -   -   1件:
13 
 559   Fish oil, rich in omega-3-acids   Fish oil   -   -   -   1件:
13 
 560   Fish oil,rich in omega 3 acids   Fish oil   -   -   -   1件:
13 
 561   Fludara   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 562   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 563   Flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   5件:
6,
13,
17,
18,
206 
 564   Fluoxetin   Fluoxetine   D00326, D00823   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
13,
179,
206 
 565   Fluoxetin hexal   Fluoxetine   D00326, D00823   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
13 
 566   Fluoxetine   Fluoxetine   D00326, D00823   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   4件:
13,
17,
78,
86 
 567   Fluoxetine hydrochloride   Fluoxetine   D00326, D00823   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
13 
 568   Flupirtin   -   -   -   -   1件:
13 
 569   Flupirtine   Flupirtine   D07978   -   -   1件:
13 
 570   Flupirtinmaleat   -   -   -   -   1件:
13 
 571   Flurbiprofen   Flurbiprofen   D00330, D01475, D02290   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   2件:
13,
46 
 572   Fmp30 donor stool   -   -   -   -   1件:
13 
 573   Folate   Folic acid   D00070   -   -   3件:
13,
46,
49 
 574   Folatescan (technetium tc 99mec20)   -   -   -   -   4件:
13,
46,
49,
96 
 575   Formulation a   -   -   -   -   1件:
13 
 576   Formulation b   -   -   -   -   1件:
13 
 577   Formulation c   -   -   -   -   1件:
13 
 578   Formulation d   -   -   -   -   1件:
13 
 579   Freshly-pressed extra virgin olive oil   Olive oil   D03311   -   -   1件:
13 
 580   Fty720   -   -   -   -   2件:
13,
14 
 581   Fty720d   -   -   -   -   1件:
13 
 582   Full spectrum vitamin   -   -   -   -   1件:
13 
 583   Fully humanized anti-human il-6 receptor (il-6r) neutralizing monoclonal antibody   -   -   -   -   1件:
13 
 584   Fumaric acid   Fumaric acid   D02308   -   -   1件:
13 
 585   G-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   12件:
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 586   G2-sfm (ifn-beta-1a from clone 484-39,fbs-free process)   -   -   -   -   1件:
13 
 587   Ga 20 mg/ml   -   -   -   -   1件:
13 
 588   Ga 40 mg/ml   -   -   -   -   1件:
13 
 589   Ga depot   -   -   -   -   1件:
13 
 590   Ga depot 40 mg   -   -   -   -   1件:
13 
 591   Ga depot 40mg once monthly   -   -   -   -   1件:
13 
 592   Ga depot 80 mg   -   -   -   -   1件:
13 
 593   Gabapentin   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   5件:
6,
13,
19,
70,
298 
 594   Gabapentine   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
13 
 595   Gabapentine 300mg   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
13 
 596   Gadobenate   Gadobenic acid   D04283, D08018   -   -   1件:
13 
 597   Gadobenate dimeglumine   Gadobenic acid   D04283, D08018   -   -   1件:
13 
 598   Gadobutrol   Gadobutrol   D07420   -   -   3件:
13,
22,
46 
 599   Gadolinium   Gadolinium   -   -   -   6件:
13,
34,
46,
58,
65,
305 
 600   Gadolinium-based contrast   Gadolinium   -   -   -   1件:
13 
 601   Gadoteric acid   Gadoteric acid   D08007   -   -   1件:
13 
 602   Gadoteridol   Gadoteridol   D01137   -   -   1件:
13 
 603   Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado   -   -   -   -   1件:
13 
 604   Gadovist 1.0 mmol/ml injektionslösung   -   -   -   -   1件:
13 
 605   Gamma-tocopherol   Tocopherol   D02332   -   -   1件:
13 
 606   Gd-dtpa-st   Pentetic acid   D05422   -   -   1件:
13 
 607   Genotropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
13,
78,
193 
 608   Gilenya   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   2件:
2,
13 
 609   Gilenya / imusera   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 610   Gilenya®   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 611   Gileyna   -   -   -   -   1件:
13 
 612   Ginkgo   Ginkgo biloba   -   -   -   3件:
6,
13,
90 
 613   Ginkgo biloba   Ginkgo biloba   -   -   -   2件:
13,
90 
 614   Ginseng   Ginseng   D06772   -   -   3件:
13,
46,
53 
 615   Glatiramer   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   4件:
2,
13,
96,
156 
 616   Glatiramer acetate   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   3件:
13,
96,
156 
 617   Glatiramer acetate (db)   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 618   Glatiramer acetate (ga)   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 619   Glatiramer acetate (ga) 40 mg   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 620   Glatiramer acetate (ol)   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 621   Glatiramer acetate 150mg enteric coated tablets   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 622   Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 623   Glatiramer acetate 20 mg   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 624   Glatiramer acetate 20 mg, with mitoxantrone   Mitoxantrone   D02166, D08224   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 625   Glatiramer acetate 20 mg/0.5 ml   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 626   Glatiramer acetate 40 mg   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 627   Glatiramer acetate injection with oral cetirizine hydrochloride   Cetirizine, Glatiramer   D00664, D04318, D07662   21件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1   35件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 628   Glatiramer acetate with minocycline   Minocycline   D00850, D05045   -   -   1件:
13 
 629   Glatiramer acetate, (copaxone®)   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 630   Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 631   Glatiramer acetate, n-acetylcysteine   Acetylcysteine   D00221   -   -   1件:
13 
 632   Glucose   D-glucose   D00009   -   -   3件:
6,
13,
299 
 633   Glutamate   Glutamic acid   D00007, D04341   -   -   1件:
13 
 634   Glutamate and aspartate   Aspartic acid, Glutamic acid   D00007, D00013, D04341   -   -   1件:
13 
 635   Glycerol   Glycerin   D00028   -   -   4件:
6,
13,
316,
317 
 636   Glycerol-1,3-didecanoate-2-octadeca-(6z,9z,12z)-trienoate   Glycerin   D00028   -   -   1件:
13 
 637   Gnbac1   -   -   -   -   1件:
13 
 638   Gnbac1 monoclonal antibody   -   -   -   -   1件:
13 
 639   Gold   Gold   -   -   -   5件:
2,
6,
13,
46,
171 
 640   Gold nanocrystals   Gold   -   -   -   3件:
2,
6,
13 
 641   Granulocyte-colony stimulating factor (g-csf) and prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 642   Growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   11件:
2,
13,
19,
46,
78,
96,
191,
193,
195,
265,
299 
 643   Gsk1223249   -   -   -   -   2件:
2,
13 
 644   Gsk1841157   -   -   -   -   3件:
13,
35,
46 
 645   Gsk2018682   Gsk2018682   -   -   -   1件:
13 
 646   Gsk2018682 cd2 capsule   Gsk2018682   -   -   -   1件:
13 
 647   Gsk239512   Gsk239512   -   -   -   1件:
13 
 648   Gsk2395612   -   -   -   -   1件:
13 
 649   Gtr.ace   -   -   -   -   1件:
13 
 650   Guanabenz   Guanabenz   D04375   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
2,
13 
 651   Gw-1000-02   -   -   -   -   1件:
13 
 652   Gz402668   -   -   -   -   1件:
13 
 653   Gz402673   -   -   -   -   1件:
13 
 654   H.p. acthar gel (repository corticotropin injection)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13 
 655   H.p. acthar® gel (repository corticotropin injection)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13 
 656   Helminth ova   -   -   -   -   1件:
13 
 657   Hematopoetic stem cell infusion   -   -   -   -   1件:
13 
 658   Hematopoietic stem cell transplantation   -   -   -   -   12件:
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 659   High dose aspirin (1300 mg/day)   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 660   High/low sodium diet   -   -   -   -   1件:
13 
 661   Histidine   Histidine   D00032   -   -   3件:
13,
169,
170 
 662   Hmr 1726d   -   -   -   -   1件:
13 
 663   Hmr1726   -   -   -   -   1件:
13 
 664   Hmr1726d   -   -   -   -   1件:
13 
 665   Hookworm larvae   -   -   -   -   1件:
13 
 666   Hp184   -   -   -   -   1件:
13 
 667   Human anti-il-12 igg1 mab   -   -   -   -   1件:
13 
 668   Human anti-il-12 mab   -   -   -   -   1件:
13 
 669   Human anti-lingo-1 monoclonal antibody   -   -   -   -   1件:
13 
 670   Human autologous mesenchymal stem cells   -   -   -   -   2件:
2,
13 
 671   Human fetal-derived neural stem cells (hnscs)   -   -   -   -   1件:
13 
 672   Human interferon beta   Human interferon beta   -   -   -   2件:
13,
26 
 673   Human interferon beta 1a (rebif)   Human interferon beta   -   -   -   1件:
13 
 674   Human interferon beta-1a and glatiramer acetate   Human interferon beta   -   -   -   1件:
13 
 675   Human leucocyte interferon-alpha   -   -   -   -   1件:
13 
 676   Human monoclonal antibody (cnto 1275) to interleukin-12p40   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   1件:
13 
 677   Human neural stem cells   -   -   -   -   2件:
2,
13 
 678   Human normal immunoglobulin   Immune globulin human   -   -   -   8件:
11,
13,
14,
43,
45,
50,
63,
65 
 679   Human recombinant growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   2件:
13,
299 
 680   Human umbilical cord mesenchymal stem cells   -   -   -   -   2件:
13,
113 
 681   Humax-cd20   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
13,
46 
 682   Hydrochlorothiazide   Hydrochlorothiazide   D00340   -   -   3件:
13,
67,
225 
 683   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 684   Hydroxytyrosol   Hydroxytyrosol   -   -   -   1件:
13 
 685   Hydroxyurea   Hydroxyurea   D00341   1件: RRM2   6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   8件:
3,
13,
19,
20,
65,
85,
86,
284 
 686   Ibudilast   Ibudilast   D01385   8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR   16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
2,
13 
 687   Ibuprofen   Ibuprofen   D00126, D01122, D04490, D06606   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   6件:
13,
46,
65,
113,
271,
299 
 688   Idebenone   Idebenone   D01750   -   -   4件:
6,
13,
113,
302 
 689   Ifa incomplete freund's adjuvant   -   -   -   -   1件:
13 
 690   Ifn beta 1 a + curcumin (bcm 95)   Curcumin   -   -   -   1件:
13 
 691   Ifn beta-1a   -   -   -   -   1件:
13 
 692   Ifn-beta-1a (rebif®)   -   -   -   -   1件:
13 
 693   Ifn-beta-1a, (avonex®)   -   -   -   -   1件:
13 
 694   Ifn-ß-1a (rebif®)   -   -   -   -   1件:
13 
 695   Ifn-ß-1a, (avonex®)   -   -   -   -   1件:
13 
 696   Il2   Human interleukin-2   -   -   -   1件:
13 
 697   Imatinib   Imatinib   D01441, D08066   3件: ABL1, KIT, PDGFRA   32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162 
 698   Imatinib mesilate   Imatinib   D01441, D08066   3件: ABL1, KIT, PDGFRA   32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   2件:
13,
86 
 699   Imatinib mesylate   Imatinib   D01441, D08066   3件: ABL1, KIT, PDGFRA   32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   5件:
13,
28,
34,
51,
86 
 700   Immune globulin   -   -   -   -   3件:
11,
13,
14 
 701   Immune globulin iv [human], 10% caprylate/chromatography purified   -   -   -   -   1件:
13 
 702   Immunoglobulin   -   -   -   -   2件:
13,
14 
 703   Immunoglobulin g   Immune globulin human   -   -   -   7件:
11,
13,
14,
49,
50,
63,
65 
 704   Impact   Topramezone   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299 
 705   Imu-838 (30 mg/day)   -   -   -   -   1件:
13 
 706   Imu-838 (45 mg/day)   -   -   -   -   1件:
13 
 707   Incabotulinumtoxina   -   -   -   -   1件:
13 
 708   Inf beta-1a   -   -   -   -   1件:
13 
 709   Influenza vaccine   -   -   -   -   4件:
11,
13,
46,
84 
 710   Inhaled cannabis   Medical cannabis   -   -   -   1件:
13 
 711   Injectable ms dmt   -   -   -   -   1件:
13 
 712   Injection of autologous stem cells   -   -   -   -   1件:
13 
 713   Injection of cell free media   -   -   -   -   1件:
13 
 714   Inn colecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
13 
 715   Inosine   Inosine   D00054   -   -   4件:
2,
6,
13,
17 
 716   Insulin   -   -   -   -   5件:
13,
46,
75,
78,
299 
 717   Int131   -   -   -   -   1件:
13 
 718   Interferon beta   Human interferon beta   -   -   -   6件:
13,
14,
20,
26,
96,
97 
 719   Interferon beta - 1a (ifn)   Human interferon beta   -   -   -   1件:
13 
 720   Interferon beta -1b   Human interferon beta   -   -   -   1件:
13 
 721   Interferon beta 1   Human interferon beta   -   -   -   1件:
13 
 722   Interferon beta 1-a   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 723   Interferon beta 1-b (betaferon/betaseron, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 724   Interferon beta 1a   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 725   Interferon beta 1a 30 ug im once weekly   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 726   Interferon beta 1a, oral doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   1件:
13 
 727   Interferon beta 1b   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 728   Interferon beta 1b (betaseron, bay86-5046)   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 729   Interferon beta treatment to add-on atorvastatin treatment   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 730   Interferon beta type 1a   Human interferon beta   -   -   -   1件:
13 
 731   Interferon beta-1 a   Human interferon beta   -   -   -   1件:
13 
 732   Interferon beta-1a   Human interferon beta   -   -   -   5件:
13,
14,
26,
96,
97 
 733   Interferon beta-1a (avonex)   Human interferon beta   -   -   -   1件:
13 
 734   Interferon beta-1a (avonex®)   Human interferon beta   -   -   -   1件:
13 
 735   Interferon beta-1a (current approved manufacturing process invloving fbs)   Human interferon beta   -   -   -   1件:
13 
 736   Interferon beta-1a (new process, manufactured without fbs)   Human interferon beta   -   -   -   1件:
13 
 737   Interferon beta-1a (rebif)   Human interferon beta   -   -   -   1件:
13 
 738   Interferon beta-1a 30 µg   Human interferon beta   -   -   -   1件:
13 
 739   Interferon beta-1a fbs-free/hsa-free, rnf   Human interferon beta   -   -   -   1件:
13 
 740   Interferon beta-1a hsa+ biosimilar   Human interferon beta   -   -   -   1件:
13 
 741   Interferon beta-1a hsa-free biosimilar   Human interferon beta   -   -   -   1件:
13 
 742   Interferon beta-1a original   Human interferon beta   -   -   -   1件:
13 
 743   Interferon beta-1b   Human interferon beta   -   -   -   1件:
13 
 744   Interferon beta-1b (betaferon, bay 86-5046)   Human interferon beta   -   -   -   1件:
13 
 745   Interferon beta-1b (betaferon, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 746   Interferon beta-1b (betaferon/betaseron, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 747   Interferon beta-1b (betaferon®, bay 86-5046)   Human interferon beta   -   -   -   1件:
13 
 748   Interferon beta-1b (betaseron, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 749   Interferon beta-1b (betaseron, betaferon, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 750   Interferon beta-1b (pf530, betaferon)   Human interferon beta   -   -   -   1件:
13 
 751   Interferon beta-1b and tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 752   Interferon beta-1b group   Human interferon beta   -   -   -   1件:
13 
 753   Interferon beta-1b, (betaseron bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 754   Interferon beta-1b/atorvastatin group   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 755   Interferon beta1a   Interferon beta1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 756   Interferon ß-1a   -   -   -   -   1件:
13 
 757   Interferon ß-1a (avonex®)   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 758   Interferon ß-1a 30 µg   -   -   -   -   1件:
13 
 759   Interferon ß-1b   -   -   -   -   1件:
13 
 760   Interferon-1beta (betaseron, bay86-5046)   -   -   -   -   1件:
13 
 761   Interferon-beta   Human interferon beta   -   -   -   2件:
13,
97 
 762   Interferon-beta (ifn-beta)   Human interferon beta   -   -   -   1件:
13 
 763   Interferon-beta 1a   Human interferon beta   -   -   -   1件:
13 
 764   Interferon-beta 1a fbs-free/hsa free, rnf   Human interferon beta   -   -   -   1件:
13 
 765   Interferon-beta 1a fbs-free/hsa-free, rnf   Human interferon beta   -   -   -   1件:
13 
 766   Interferon-beta 1b   Human interferon beta   -   -   -   1件:
13 
 767   Interferon-beta 1b (betaseron)   Human interferon beta   -   -   -   1件:
13 
 768   Interferon-beta-1a   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
13,
97 
 769   Interferon-beta-1a fbs-free/hsa free, rnf   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 770   Interferon-beta-1a fbs-free/hsa-free   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 771   Interferon-beta-1b   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 772   Interferon-beta1   Human interferon beta   -   -   -   1件:
13 
 773   Interferon-ß-1a   -   -   -   -   1件:
13 
 774   Interferon-ß-1b   -   -   -   -   1件:
13 
 775   Intradetrusor injection of botulinum toxin-a   -   -   -   -   1件:
13 
 776   Intratect   -   -   -   -   3件:
13,
35,
65 
 777   Intrathecal administration of autologous msc-np   -   -   -   -   1件:
13 
 778   Intrathecal methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   1件:
13 
 779   Intrathecal msc-np injection   -   -   -   -   1件:
13 
 780   Intravenous (iv) infusions   -   -   -   -   1件:
13 
 781   Intravenous injection of mesenchymal stem cells   -   -   -   -   1件:
13 
 782   Intravenous steroid   -   -   -   -   1件:
13 
 783   Ipx056   -   -   -   -   1件:
13 
 784   Ipx056-10 mg   -   -   -   -   1件:
13 
 785   Ipx056-20 mg   -   -   -   -   1件:
13 
 786   Ipx056-30 mg   -   -   -   -   1件:
13 
 787   Ipx056-35 mg   -   -   -   -   1件:
13 
 788   Ipx056-40 mg   -   -   -   -   1件:
13 
 789   Ir902   -   -   -   -   1件:
13 
 790   Iron   Iron   -   -   -   7件:
13,
62,
86,
96,
97,
254,
284 
 791   Iron oxide   Iron   -   -   -   1件:
13 
 792   Isentress   Raltegravir   D06676   -   -   1件:
13 
 793   Isoxsuprine   Isoxsuprine   D08092   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 794   Isoxsuprine hydrochloride   Isoxsuprine   D08092   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 795   Iv methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 796   Iv methylprednisolone (steroids)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 797   Ivig   Immune globulin human   -   -   -   12件:
11,
13,
14,
17,
18,
50,
51,
63,
65,
85,
164,
296 
 798   Ixazomib   Ixazomib   D10130   1件: PSMB5   1件: Proteasome   3件:
13,
16,
28 
 799   Ixazomib (ninlaro®) capsules   Ixazomib   D10130   1件: PSMB5   1件: Proteasome   1件:
13 
 800   Jm-4   -   -   -   -   1件:
13 
 801   Kemstro   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 802   Kepivance   Palifermin   D05338   1件: FGFR2   12件: Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells   1件:
13 
 803   Keppra   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   1件:
13 
 804   Keppra 250mg   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   1件:
13 
 805   Keppra 500mg   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   1件:
13 
 806   Keppra ®   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   1件:
13 
 807   Ketamine   Ketamine   D00711, D08098   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   5件:
13,
70,
113,
156,
215 
 808   Ketoconazole   Ketoconazole   D00351   1件: CYP17A1   6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   3件:
8,
13,
75 
 809   Keyhole limpet hemocyanin   Keyhole limpet hemocyanin   -   -   -   2件:
13,
46 
 810   Keyhole limpet hemocyanin (klh)   Keyhole limpet hemocyanin   -   -   -   1件:
13 
 811   Keyhole limpet hemocyanin (klh) neo-antigen   Keyhole limpet hemocyanin   -   -   -   1件:
13 
 812   L acetyl carnitine   Levocarnitine   D02030, D02176, D04713   -   -   1件:
13 
 813   L-000124467   -   -   -   -   2件:
13,
46 
 814   L-carnitine   Levocarnitine   D02030, D02176, D04713   -   -   6件:
13,
96,
97,
265,
298,
316 
 815   L-histidine   Histidine   D00032   -   -   1件:
13 
 816   L04aa04 - immunoglobulina antitimocitaria (di coniglio) immunoglobulina di coniglio antitimociti umani thymoglobuline   -   -   -   -   1件:
13 
 817   L04aa31   -   -   -   -   1件:
13 
 818   L04ax01   -   -   -   -   1件:
13 
 819   Lactose   Lactose   D00046, D03226   -   -   6件:
2,
6,
13,
97,
228,
310 
 820   Lactose monohydrate   Lactose   D00046, D03226   -   -   1件:
13 
 821   Lamotrigine   Lamotrigine   D00354   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   3件:
13,
34,
114 
 822   Lamotrigine extended release tablets   Lamotrigine   D00354   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
13 
 823   Laquinimod   Laquinimod   -   -   -   4件:
8,
13,
49,
96 
 824   Laquinimod 0.6   Laquinimod   -   -   -   1件:
13 
 825   Laquinimod 1.2   Laquinimod   -   -   -   1件:
13 
 826   Laquinimod capsules 0.3 mg   Laquinimod   -   -   -   1件:
13 
 827   Laquinimod capsules 0.6 mg   Laquinimod   -   -   -   1件:
13 
 828   Laquinimod sodium (usan)   Laquinimod   -   -   -   1件:
13 
 829   Laquinimod tablets 0.3 mg   Laquinimod   -   -   -   1件:
13 
 830   Lemtrada   Alemtuzumab   D02802   -   -   2件:
13,
65 
 831   Lemtrada 12 mg konzentrat zur herstellung einer infusionslösung   Alemtuzumab   D02802   -   -   1件:
13 
 832   Levetiracetam   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   4件:
2,
4,
6,
13 
 833   Levitra   Vardenafil   D02731, D03260, D08668   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   2件:
13,
86 
 834   Levocarnil   -   -   -   -   1件:
13 
 835   Levofolene   Levoleucovorin   D04715   -   -   1件:
13 
 836   Levofolene 4 mg 30 cpr   Levoleucovorin   D04715   -   -   1件:
13 
 837   Levonorgestrel   Levonorgestrel   D00950   1件: PGR   4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
13 
 838   Lfb-r603   -   -   -   -   1件:
13 
 839   Lidocaine   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   8件:
6,
13,
46,
86,
168,
226,
231,
256 
 840   Lidocaine patch 5%   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
13 
 841   Linoleic acid   Linoleic acid   -   -   -   1件:
13 
 842   Linoleic acid/oleic acid   Linoleic acid   -   -   -   1件:
13 
 843   Liothyronine   Liothyronine   D01011, D08128   2件: THRA, THRB   2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   2件:
13,
212 
 844   Liothyronine sodium   Liothyronine   D01011, D08128   2件: THRA, THRB   2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   1件:
13 
 845   Lipoic acid   Lipoic acid   D00048, D00086   -   -   5件:
2,
5,
13,
14,
20 
 846   Lipoic acid (la) with fish oil and la without fish oil   Lipoic acid   D00048, D00086   -   -   1件:
13 
 847   Lipoic acid and omega-3 fatty acids   Lipoic acid   D00048, D00086   -   -   1件:
13 
 848   Lisdexamfetamine   Lisdexamfetamine   D08130   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 849   Lisdexamfetamine sulfate   Lisdexamfetamine   D08130   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 850   Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field   -   -   -   -   1件:
13 
 851   Lithium carbonate   Lithium carbonate   D00801   -   -   5件:
2,
13,
17,
19,
127 
 852   Live hookworm larvae   -   -   -   -   1件:
13 
 853   Live necator americanus larvae   -   -   -   -   1件:
13 
 854   Loperamide   Loperamide   D00729, D07113, D08144   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   2件:
13,
97 
 855   Loratadine   Loratadine   D00364   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   2件:
13,
46 
 856   Losartan   Losartan   D00357, D08146   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 857   Low dose arm receiving neutral oil and 400 iu/g of vitamin d every second day   Vitamin d   -   -   -   1件:
13 
 858   Low dose aspirin (162 mg/day)   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 859   Low immunogenic interferon-beta-1a   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 860   Lubiprostone   Lubiprostone   D04790   1件: CLCN2   1件: Mineral absorption   4件:
6,
13,
290,
299 
 861   Lumbar puncture   -   -   -   -   3件:
13,
96,
97 
 862   Lutenyl   -   -   -   -   1件:
13 
 863   Ly2127399   -   -   -   -   3件:
13,
46,
49 
 864   Ly248686   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
13 
 865   Lysine   L-lysine   D02304   -   -   4件:
13,
97,
228,
299 
 866   M2951   -   -   -   -   3件:
13,
46,
49 
 867   Mabcampath   Alemtuzumab   D02802   -   -   1件:
13 
 868   Mabcampath ®   Alemtuzumab   D02802   -   -   1件:
13 
 869   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 870   Mabthera (rituximab)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   4件:
13,
46,
49,
53 
 871   Mabthera or biosimilar rituximab product   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 872   Mabthera®   -   -   -   -   6件:
13,
35,
43,
44,
46,
93 
 873   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 874   Maltodextrin   Maltodextrin   D02329   -   -   4件:
6,
13,
96,
97 
 875   Maltodextrin fiber supplement   Maltodextrin   D02329   -   -   1件:
13 
 876   Mangafodipir   Mangafodipir   D08262   -   -   2件:
13,
58 
 877   Mangafodipir (teslascan)   Mangafodipir   D08262   -   -   1件:
13 
 878   Mannose   Mannose   -   -   -   2件:
13,
256 
 879   Mantadan*20cpr 100mg   -   -   -   -   1件:
13 
 880   Marijuana   Medical cannabis   -   -   -   1件:
13 
 881   Masitinb mesylate   -   -   -   -   1件:
13 
 882   Masitinib   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 883   Masitinib mesylate   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 884   Mastinib   -   -   -   -   1件:
13 
 885   Mavenclad®   -   -   -   -   1件:
13 
 886   Mbp peptide   -   -   -   -   1件:
13 
 887   Mbp8298   -   -   -   -   1件:
13 
 888   Mbp8298 synthetic peptide   -   -   -   -   1件:
13 
 889   Md1003   -   -   -   -   5件:
2,
10,
13,
14,
20 
 890   Md1003 100mg capsule   -   -   -   -   1件:
13 
 891   Medi-551   -   -   -   -   1件:
13 
 892   Medi-551 iv   -   -   -   -   1件:
13 
 893   Medi-551 sc   -   -   -   -   1件:
13 
 894   Medical marijuana   Medical cannabis   -   -   -   1件:
13 
 895   Medrol   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
222 
 896   Megadose oral methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 897   Melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202 
 898   Melphalan   Melphalan   D00369   -   -   14件:
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285 
 899   Memantine   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   7件:
2,
6,
8,
13,
49,
127,
205 
 900   Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)   -   -   -   -   1件:
13 
 901   Menitorix   -   -   -   -   1件:
13 
 902   Mesenchymal stem cells   -   -   -   -   11件:
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 903   Mesenchymal stem cells (mscs)   -   -   -   -   3件:
13,
36,
96 
 904   Mesenchymal stem/stromal cells   -   -   -   -   1件:
13 
 905   Mesna   Coenzyme m   -   -   -   9件:
13,
44,
45,
49,
51,
60,
65,
96,
164 
 906   Metex   -   -   -   -   1件:
13 
 907   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 908   Methelphenidate   -   -   -   -   1件:
13 
 909   Methotrexat   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   3件:
13,
46,
50 
 910   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 911   Methyl b12   -   -   -   -   1件:
13 
 912   Methyl folate   Folic acid   D00070   -   -   1件:
13 
 913   Methyloprednisolone   -   -   -   -   1件:
13 
 914   Methylphenidate   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   7件:
6,
13,
34,
84,
113,
179,
206 
 915   Methylphenidate hydrochloride   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   2件:
6,
13 
 916   Methylphenidate modified release   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 917   Methylphenidate modified release 20 mg   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 918   Methylphenidate modified release 30 mg   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 919   Methylphenidate modified release 40 mg   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 920   Methylprednisolon   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   4件:
13,
51,
66,
222 
 921   Methylprednisolon-21-hydrogensuccinat, natriumsalz   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 922   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 923   Methylprednisolone (drug)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 924   Methylprednisolone hemisuccinate   Methylprednisolone hemisuccinate   D05000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 925   Methylprednisolone iv   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 926   Methylprednisolone sodium hemisuccinate   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 927   Methylprednisolone sodium succinate   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
13,
46,
51 
 928   Microgynon   -   -   -   -   2件:
13,
51 
 929   Microgynon®   -   -   -   -   1件:
13 
 930   Micropirin   -   -   -   -   1件:
13 
 931   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 932   Mineral boost (magnesium)   Magnesium   -   -   -   1件:
13 
 933   Minocycline   Minocycline   D00850, D05045   -   -   13件:
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 934   Minocycline 100 mg film-coated tablets   Minocycline   D00850, D05045   -   -   1件:
13 
 935   Minocycline hydrochloride   Minocycline   D00850, D05045   -   -   4件:
13,
201,
206,
299 
 936   Mirabegron   Mirabegron   D09535   1件: ADRB3   7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway   3件:
6,
13,
226 
 937   Mis416   -   -   -   -   1件:
13 
 938   Mitoquinone   Mitoquinone   -   -   -   1件:
13 
 939   Mitoxantrone   Mitoxantrone   D02166, D08224   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 940   Mk0812   Mk0812   -   -   -   2件:
13,
46 
 941   Mln1202   -   -   -   -   1件:
13 
 942   Modafinil   Modafinil   D01832   -   -   4件:
6,
13,
49,
93 
 943   Mog peptide   -   -   -   -   1件:
13 
 944   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 945   Monoclonal antibody m-t412   -   -   -   -   1件:
13 
 946   Montelukast   Montelukast   D00529, D08229   1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   5件:
13,
46,
85,
98,
228 
 947   Mor103   -   -   -   -   2件:
13,
46 
 948   Msc2015   -   -   -   -   1件:
13 
 949   Msc2304479a   -   -   -   -   1件:
13 
 950   Msc2304480a   -   -   -   -   1件:
13 
 951   Msc2304481a   -   -   -   -   1件:
13 
 952   Msc2304482a   -   -   -   -   1件:
13 
 953   Msc2358825a   -   -   -   -   1件:
13 
 954   Msc2430913a or ono-4641 (to be used as synonyms)   -   -   -   -   1件:
13 
 955   Msc2491529a   -   -   -   -   1件:
13 
 956   Msdmds other than betaseron (interferon beta-1b, bay86-5046)   Human interferon beta   -   -   -   1件:
13 
 957   Mstc-001 (ms-stat)   -   -   -   -   1件:
13 
 958   Mt-1303   -   -   -   -   2件:
13,
96 
 959   Mt-1303-forma   -   -   -   -   1件:
13 
 960   Mt-1303-formb   -   -   -   -   1件:
13 
 961   Mt-1303-high   -   -   -   -   1件:
13 
 962   Mt-1303-low   -   -   -   -   1件:
13 
 963   Mt-1303-middle   -   -   -   -   1件:
13 
 964   Multiferon   -   -   -   -   1件:
13 
 965   Multiple (4 autologous subcutaneous t cell vaccinations with t cell lines reactive to nine myelin peptides)   -   -   -   -   1件:
13 
 966   Mutagrip   -   -   -   -   2件:
11,
13 
 967   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 968   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 969   Mycophenolate mofetil (cellcept)   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
11,
13 
 970   N acetylcysteine   Acetylcysteine   D00221   -   -   1件:
13 
 971   N-acetyl cysteine   L-cysteine   D00026, D02326   -   -   5件:
13,
19,
85,
88,
296 
 972   N-acetylcysteine   Acetylcysteine   D00221   -   -   10件:
6,
13,
19,
20,
49,
58,
85,
111,
164,
299 
 973   N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine   -   -   -   -   1件:
13 
 974   N.a.   -   -   -   -   8件:
3,
6,
8,
13,
46,
97,
240,
256 
 975   N02bg10   -   -   -   -   1件:
13 
 976   N03ax12   -   -   -   -   1件:
13 
 977   N06dx01   -   -   -   -   1件:
13 
 978   Nabilone   Nabilone   D05099   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   2件:
6,
13 
 979   Naltrexone   Naltrexone   D02095, D05113   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 980   Namisol   -   -   -   -   2件:
13,
298 
 981   Nanocort   -   -   -   -   3件:
13,
46,
97 
 982   Nanocurcumin   -   -   -   -   2件:
13,
271 
 983   Naproxen   Naproxen   D00118   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   3件:
13,
46,
271 
 984   Natalizumab   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   4件:
13,
15,
46,
96 
 985   Natalizumab (bg00002)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 986   Natalizumab (ntz)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 987   Natalizumab (tysabri)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 988   Natalizumab for iv infusion   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 989   Natalizumab for subcutaneous injection   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 990   Natalizumab treatment   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 991   Nbi-5788   -   -   -   -   1件:
13 
 992   Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection   Testosterone undecanoate   D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   1件:
13 
 993   Necator americanus   -   -   -   -   1件:
13 
 994   Neorecormon   -   -   -   -   1件:
13 
 995   Nerispirdine   Nerispirdine   -   -   -   1件:
13 
 996   Nerispirdine (hp184)   Nerispirdine   -   -   -   1件:
13 
 997   Nerispirdine hydrochloride   Nerispirdine   -   -   -   1件:
13 
 998   Neupogen   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   4件:
13,
28,
51,
285 
 999   Neuroaspis plp10®   -   -   -   -   1件:
13 
 1000   Neurontin   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
13 
 1001   Neurontin 300 mg hard capsule   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
13 
 1002   Neurovax   -   -   -   -   1件:
13 
 1003   Neurovax 300ug/ml dose for im injection   -   -   -   -   1件:
13 
 1004   New formulation of rebif - human interferon beta-1a   Human interferon beta   -   -   -   1件:
13 
 1005   Niacinamide   Nicotinamide   D00036   -   -   4件:
5,
6,
13,
67 
 1006   Nitrofurantoin   Nitrofurantoin   D00439   -   -   1件:
13 
 1007   Nivolumab   Nivolumab   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97 
 1008   Nomegestrol   Nomegestrol   D07222   1件: PGR   4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
13 
 1009   Nomegestrol acetate   Nomegestrol acetate   D08281   1件: PGR   4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
13 
 1010   Non-pegylated interferon   -   -   -   -   1件:
13 
 1011   Norethindrone   Norethisterone   D00182, D00953   1件: PGR   4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   4件:
13,
46,
49,
299 
 1012   Normal saline for injection   -   -   -   -   1件:
13 
 1013   Novantrone*inf 2mg/ml 5ml   Mitoxantrone   D02166, D08224   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 1014   Npb-01   -   -   -   -   3件:
13,
14,
162 
 1015   Nt-ko-003   -   -   -   -   1件:
13 
 1016   Nu100   -   -   -   -   1件:
13 
 1017   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 1018   Nurown (msc-ntf cells)   -   -   -   -   1件:
13 
 1019   Ocrelizumab   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   3件:
13,
46,
49 
 1020   Ocrelizumab 300 mg   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1021   Ocrelizumab 300mg   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1022   Ocrelizumab 300mg /10ml   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1023   Ocrelizumab 300mg/10ml   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1024   Ocrelizumab 600 mg   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1025   Ocrelizumab dose 1   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1026   Ocrelizumab dose 2 and dose 3   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1027   Ocrevus   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1028   Octagam 5%   -   -   -   -   2件:
13,
65 
 1029   Octagam 50 mg/ml   -   -   -   -   1件:
13 
 1030   Ofatumumab   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   3件:
13,
35,
46 
 1031   Ofatumumab 100   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1032   Ofatumumab 300   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1033   Ofatumumab 30mg   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1034   Ofatumumab 3mg   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1035   Ofatumumab 60mg   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1036   Ofatumumab 700   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1037   Ofatumumab subcutaneous injection   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1038   Oleic acid   Oleic acid   D02315   -   -   1件:
13 
 1039   Oleovit d3 14.400 iu/ml oral drops, solution   -   -   -   -   1件:
13 
 1040   Olesoxime (tro19622)   Tro19622   -   -   -   1件:
13 
 1041   Olive   Olea europaea leaf   -   -   -   3件:
13,
49,
53 
 1042   Olive oil   Olive oil   D03311   -   -   3件:
13,
49,
53 
 1043   Omb157   -   -   -   -   1件:
13 
 1044   Omega 3   Omega-3 fatty acids   -   -   -   2件:
13,
299 
 1045   Omega 3 fatty acids   Omega-3 fatty acids   -   -   -   1件:
13 
 1046   Omega-3   Omega-3 fatty acids   -   -   -   7件:
13,
46,
49,
66,
79,
96,
299 
 1047   Omega-3 fatty acids   Omega-3 fatty acids   -   -   -   2件:
13,
79 
 1048   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 1049   Onabotulinumtoxina   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   3件:
6,
13,
226 
 1050   Ono-4641   -   -   -   -   1件:
13 
 1051   Ono-4641/msc2430913a   -   -   -   -   1件:
13 
 1052   Opicinumab   Opicinumab   -   -   -   1件:
13 
 1053   Oral lipoic acid (la)   Lipoic acid   D00048, D00086   -   -   1件:
13 
 1054   Oral thc   -   -   -   -   1件:
13 
 1055   Ory2001   -   -   -   -   1件:
13 
 1056   Os440   -   -   -   -   1件:
13 
 1057   Other disease-modifying therapy   -   -   -   -   1件:
13 
 1058   Other h1 antagonist   -   -   -   -   1件:
13 
 1059   Other nervous system drugs   -   -   -   -   2件:
6,
13 
 1060   Ovastat   Treosulfan   D07253   -   -   2件:
13,
65 
 1061   Ovastat 1000   Treosulfan   D07253   -   -   1件:
13 
 1062   Ovastat 5000   Treosulfan   D07253   -   -   1件:
13 
 1063   Oxcarbazepine   Oxcarbazepine   D00533   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
13 
 1064   Oxine   Oxyquinoline   D05321   -   -   1件:
13 
 1065   Oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   7件:
6,
13,
46,
70,
226,
231,
298 
 1066   Ozanimod   Ozanimod   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   3件:
13,
96,
97 
 1067   Ozanimod 0.5 mg   Ozanimod   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1068   Ozanimod 1 mg   Ozanimod   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1069   Ozanimod hydrochloride   Ozanimod   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   3件:
13,
96,
97 
 1070   Palifermin   Palifermin   D05338   1件: FGFR2   12件: Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells   4件:
13,
38,
39,
65 
 1071   Pantoprazole   Pantoprazole   D02593, D05353   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   2件:
13,
65 
 1072   Paracetamol   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   5件:
3,
6,
13,
35,
46 
 1073   Paroxetine   Paroxetine   D02260, D02362, D05374, D05375   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
46 
 1074   Part a: 100 mg/ml gsk2618960   -   -   -   -   1件:
13 
 1075   Part b: dose of gsk2618960 decided from part a   -   -   -   -   1件:
13 
 1076   Part c: dose of gsk2618960 decided from part a and b   -   -   -   -   1件:
13 
 1077   Peg-liposomal prednisolone sodium phosphate   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97 
 1078   Peginterferon beta-1a   -   -   -   -   1件:
13 
 1079   Pegylated intereron beta-1a   -   -   -   -   1件:
13 
 1080   Pegylated interferon beta-1a   Human interferon beta   -   -   -   1件:
13 
 1081   Pending   -   -   -   -   3件:
13,
113,
302 
 1082   Pent   Pentaerythritol tetranitrate   D01721   -   -   1件:
13 
 1083   Pet with 11c-flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
13 
 1084   Pf-06342674 0.25 mg/kg   -   -   -   -   1件:
13 
 1085   Pf-06342674 1.5 mg/kg   -   -   -   -   1件:
13 
 1086   Pf-06342674 6.0 mg/kg   -   -   -   -   1件:
13 
 1087   Phenylcyclopropylamine derivatives and dual lsd1/mao-b (lysine-specific demethylase 1 and monoamine oxidase-b) inhibitor   L-lysine   D02304   -   -   1件:
13 
 1088   Phenytoin   Phenytoin   D00512, D02103   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
13 
 1089   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 1090   Pi-2301   -   -   -   -   1件:
13 
 1091   Pioglitazone   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 1092   Pixantrone   Pixantrone   D05522   2件: TOP2A, TOP2B   1件: Platinum drug resistance   2件:
11,
13 
 1093   Pl 04515/0127   -   -   -   -   1件:
13 
 1094   Pl 12762/0049   -   -   -   -   1件:
13 
 1095   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 1096   Platelet transfusion   -   -   -   -   1件:
13 
 1097   Plegridy   Peginterferon beta-1a   D10483   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1098   Plegridy (peginterferon beta-1a), biogen idec ltd   Peginterferon beta-1a   D10483   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1099   Plegridy 125 micrograms   Peginterferon beta-1a   D10483   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1100   Pleneva tm bgc20-0134   -   -   -   -   1件:
13 
 1101   Plovamer acetate   Acetate   -   -   -   1件:
13 
 1102   Plp peptide   -   -   -   -   1件:
13 
 1103   Pneumovax ii   -   -   -   -   1件:
13 
 1104   Pnu-215062 sodium salt   -   -   -   -   1件:
13 
 1105   Polyphenon e   -   -   -   -   2件:
13,
36 
 1106   Ponesimod   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1107   Ponesimod 10 mg   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1108   Ponesimod 20 mg   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1109   Ponesimod 40 mg   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1110   Pravastatin   Pravastatin   D00893, D08410   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   9件:
13,
46,
49,
67,
79,
96,
164,
265,
333 
 1111   Prebiotics (prebiotin prebiotic fiber stick pac)   -   -   -   -   1件:
13 
 1112   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 1113   Prednisolone sodium phosphate   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97 
 1114   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 1115   Pregabalin   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   5件:
13,
36,
46,
70,
298 
 1116   Prepulsid   -   -   -   -   1件:
13 
 1117   Prn2246   -   -   -   -   1件:
13 
 1118   Probiotics (visbiome®)   -   -   -   -   1件:
13 
 1119   Prohance (gadoteridol)   Gadoteridol   D01137   -   -   1件:
13 
 1120   Prolonged-release fampridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 1121   Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal)   -   -   -   -   1件:
13 
 1122   Provigil   Modafinil   D01832   -   -   1件:
13 
 1123   Provigil (modafinil)   Modafinil   D01832   -   -   1件:
13 
 1124   Prucalopride   Prucalopride   D09205   1件: HTR4   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway   3件:
13,
51,
96 
 1125   Ptl201   -   -   -   -   1件:
13 
 1126   Quetiapine   Quetiapine   D00458, D08456   2件: DRD2, HTR2A   11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   2件:
6,
13 
 1127   Quinidine   Quinidine   D00642, D00643, D02272, D08458   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   3件:
2,
8,
13 
 1128   R lipoic acid   Lipoic acid   D00048, D00086   -   -   1件:
13 
 1129   Rabbit   Rabbit   -   -   -   7件:
13,
49,
51,
60,
65,
96,
285 
 1130   Rabbit human t lymphocyte immunoglobulin   Rabbit   -   -   -   2件:
13,
60 
 1131   Ralenova   Mitoxantrone   D02166, D08224   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 1132   Raltegravir   Raltegravir   D06676   -   -   4件:
13,
26,
93,
265 
 1133   Ramatroban   Ramatroban   D01128   2件: PTGDR, TBXA2R   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation   1件:
13 
 1134   Ranitidine   Ranitidine   D00422, D00673   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   2件:
13,
65 
 1135   Raptiva 100 mg/ml powder and solvent for solution for injection   Efalizumab   D03959   1件: ITGAL   11件: Cell adhesion molecules (CAMs), Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis   7件:
11,
13,
46,
53,
61,
95,
96 
 1136   Ratg   -   -   -   -   2件:
13,
51 
 1137   Rc18 160 mg   -   -   -   -   2件:
13,
53 
 1138   Rebif   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1139   Rebif (ifn beta-1a subcutaneous three times per week)   -   -   -   -   1件:
13 
 1140   Rebif (ifn ß-1a subcutaneous three times per week)   -   -   -   -   1件:
13 
 1141   Rebif (ifnbeta-1b)   -   -   -   -   1件:
13 
 1142   Rebif (ifnß-1b)   -   -   -   -   1件:
13 
 1143   Rebif (interferon beta 1a)   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1144   Rebif (interferon beta-1a)   Human interferon beta   -   -   -   1件:
13 
 1145   Rebif (interferon beta-1a), merck serono europe ltd   Human interferon beta   -   -   -   1件:
13 
 1146   Rebif 22   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1147   Rebif 22 micrograms   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1148   Rebif 22 y 44 mcg   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1149   Rebif 22®   -   -   -   -   1件:
13 
 1150   Rebif 44   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1151   Rebif 44 microgramos solución inyectable   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1152   Rebif 44 micrograms   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1153   Rebif 44 µg   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1154   Rebif 44®   -   -   -   -   1件:
13 
 1155   Rebif 8,8 µg, rebif 22µg   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1156   Rebif new formulation + ibuprofen prn   Ibuprofen   D00126, D01122, D04490, D06606   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 1157   Rebif new formulation + prophylactic ibuprofen   Ibuprofen   D00126, D01122, D04490, D06606   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 1158   Rebif new formulation 44mcg multidose cartridge   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1159   Rebif new formulation non titrated   -   -   -   -   1件:
13 
 1160   Rebif new formulation titrated   -   -   -   -   1件:
13 
 1161   Rebif sc 12sir 12000000ui44mcg   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1162   Rebif sc 12sir 6000000ui 22mcg   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1163   Rebif*sc 12sir 12000000ui44mcg   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1164   Rebif®   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1165   Rebif® (clone 484-39)   -   -   -   -   1件:
13 
 1166   Rebif® new formulation   -   -   -   -   1件:
13 
 1167   Rebif® new formulation (rnf)   -   -   -   -   1件:
13 
 1168   Rebif® new formulation (rnf) using rebismarttm   -   -   -   -   1件:
13 
 1169   Recombinant human alpha b-crystallin   -   -   -   -   1件:
13 
 1170   Recombinant human erythropoietin   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
13 
 1171   Recombinant human interferon beta   Human interferon beta   -   -   -   1件:
13 
 1172   Recombinant humanized anti-alpha 4 integrin antibody   -   -   -   -   1件:
13 
 1173   Recombinant interferon beta-1b   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 1174   Repository corticotropin injection   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
2,
13,
46,
84,
222 
 1175   Revaxis   -   -   -   -   1件:
13 
 1176   Rg2077 (ctla4-igg4m)   -   -   -   -   1件:
13 
 1177   Rhb-104   -   -   -   -   2件:
13,
96 
 1178   Rhepo   -   -   -   -   1件:
13 
 1179   Rhifn beta-1b   -   -   -   -   1件:
13 
 1180   Rhigf-1 (cep-151)   -   -   -   -   1件:
13 
 1181   Rhigm22   -   -   -   -   1件:
13 
 1182   Rhumab 2h7   -   -   -   -   3件:
13,
46,
49 
 1183   Rhumab to il-17a (igg1-k-class)   -   -   -   -   2件:
13,
46 
 1184   Rhuph20   -   -   -   -   2件:
13,
14 
 1185   Riboflavin   Riboflavin   D00050, D01622, D01913   -   -   8件:
13,
38,
46,
96,
97,
162,
168,
265 
 1186   Rifampin   Rifampicin   D00211   -   -   5件:
6,
13,
84,
86,
299 
 1187   Riluzole   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   7件:
2,
3,
5,
8,
13,
17,
206 
 1188   Ritalin   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   2件:
6,
13 
 1189   Ritalin la 20mg capsules   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 1190   Ritalin la 30mg capsules   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 1191   Ritalin la 40mg capsules   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
13 
 1192   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 1193   Rituximab infusion   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
13,
222 
 1194   Rituximab it   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1195   Rituximab iv   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1196   Rivastigmin   -   -   -   -   1件:
13 
 1197   Rivastigmine   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
5,
6,
13 
 1198   Rivastigmine transdermal patch   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
13 
 1199   Rns60   -   -   -   -   2件:
2,
13 
 1200   Rns60 125 ml   -   -   -   -   1件:
13 
 1201   Rns60 250 ml   -   -   -   -   1件:
13 
 1202   Ro 496-4913/f07   -   -   -   -   1件:
13 
 1203   Ro0506997   -   -   -   -   2件:
13,
46 
 1204   Ro4964913   -   -   -   -   1件:
13 
 1205   Ro4964913 f07   -   -   -   -   1件:
13 
 1206   Ro4964913/f03   -   -   -   -   1件:
13 
 1207   Ro4964913/f07   -   -   -   -   1件:
13 
 1208   Ro4964913/f07-01   -   -   -   -   1件:
13 
 1209   Ro4964913/f07-01 (commercial)   -   -   -   -   1件:
13 
 1210   Ro4964913/f07-01 (development)   -   -   -   -   1件:
13 
 1211   Rolipram   Rolipram   D01783   4件: PDE4A, PDE4B, PDE4C, PDE4D   5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway   2件:
8,
13 
 1212   Rpc-1063   -   -   -   -   1件:
13 
 1213   Rpc1063   -   -   -   -   3件:
13,
96,
97 
 1214   Rtl1000 (recombinant t cell receptor ligand)   -   -   -   -   1件:
13 
 1215   S-warfarin   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   1件:
13 
 1216   Sa237   -   -   -   -   1件:
13 
 1217   Sa237-120 pfs with nsd   -   -   -   -   1件:
13 
 1218   Sa237-120/vial   -   -   -   -   1件:
13 
 1219   Saline   Sodium chloride   D02056   -   -   10件:
6,
13,
17,
53,
67,
78,
86,
97,
168,
299 
 1220   Sar339658   -   -   -   -   2件:
13,
97 
 1221   Sar442168   -   -   -   -   1件:
13 
 1222   Sativex   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   2件:
2,
13 
 1223   Sativex oromucosal spray   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 1224   Sativex®   -   -   -   -   1件:
13 
 1225   Satralizumab   -   -   -   -   1件:
13 
 1226   Satralizumab (r-inn)   -   -   -   -   1件:
13 
 1227   Sb-683699   -   -   -   -   1件:
13 
 1228   Sb683699   -   -   -   -   1件:
13 
 1229   Sc interferon beta-1a   Human interferon beta   -   -   -   1件:
13 
 1230   Sc interferon beta-1b   Human interferon beta   -   -   -   1件:
13 
 1231   Sc peginterferon beta-1a   -   -   -   -   1件:
13 
 1232   Sclerolym   -   -   -   -   1件:
13 
 1233   Seasonal quadrivalent influenza vaccine   -   -   -   -   1件:
13 
 1234   Second-generation fumaric acid   Fumaric acid   D02308   -   -   1件:
13 
 1235   Secukinumab   Secukinumab   D09967   1件: IL17A   5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Th17 cell differentiation   7件:
13,
37,
41,
46,
160,
269,
271 
 1236   Selenium   Selenium   -   -   -   2件:
13,
278 
 1237   Sendoxan   -   -   -   -   1件:
13 
 1238   Serum containing avonex   -   -   -   -   1件:
13 
 1239   Serum free avonex   -   -   -   -   1件:
13 
 1240   Sh u 555 c   -   -   -   -   1件:
13 
 1241   Silodyx   Silodosin   D01965   1件: ADRA1A   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
13 
 1242   Simethicone   Simethicone   D05841   -   -   2件:
13,
96 
 1243   Simvahexal® 40 mg filmtabletten   -   -   -   -   1件:
13 
 1244   Simvastatin   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 1245   Simvastatin 40 mg film-coated tablets   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1246   Simvastatin alternova   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1247   Simvastatina   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1248   Simvastatina sandoz 40 mg comprimidos recubiertos con película efg   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1249   Simvastatine   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   2件:
6,
13 
 1250   Simvastatine sandoz 40 mg filmomhulde tabletten   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1251   Simvastatine sandoz 40mg deelbare filmomhulde tabletten   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1252   Sinvastatina sandoz 40 mg comprimidos revestidos por película   -   -   -   -   1件:
13 
 1253   Siponimod   Siponimod   D11460   2件: S1PR1, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   2件:
13,
50 
 1254   Siponimod 0.25 mg tablet   Siponimod   D11460   2件: S1PR1, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1255   Siponimod 0.5 mg tablet   Siponimod   D11460   2件: S1PR1, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1256   Siponimod 1 mg tablet   Siponimod   D11460   2件: S1PR1, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1257   Siponimod 2 mg tablet   Siponimod   D11460   2件: S1PR1, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 1258   Sirolimus   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 1259   Sivatin 40 mg film-coated tablets   -   -   -   -   1件:
13 
 1260   Sivelestat   Sivelestat   D03788   1件: ELANE   2件: Systemic lupus erythematosus, Transcriptional misregulation in cancer   3件:
13,
85,
96 
 1261   Smderpept   -   -   -   -   1件:
13 
 1262   Smoked cannabis   Medical cannabis   -   -   -   1件:
13 
 1263   Sodium chlorid   -   -   -   -   1件:
13 
 1264   Sodium chloride   Sodium chloride   D02056   -   -   13件:
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 1265   Sodium chloride solution   Sodium chloride   D02056   -   -   3件:
11,
13,
228 
 1266   Soliris   Eculizumab   D03940   1件: C5   7件: Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   7件:
11,
13,
14,
62,
109,
222,
223 
 1267   Solu-medrol   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97 
 1268   Solu-moderin 1 g   -   -   -   -   1件:
13 
 1269   Solumedrol   -   -   -   -   1件:
13 
 1270   Somatorelin   Somatorelin   D08523   1件: GHRHR   2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction   2件:
13,
78 
 1271   Spiropent   -   -   -   -   1件:
13 
 1272   Sr-fampridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 1273   Ss-interferon   -   -   -   -   1件:
13 
 1274   Standard gadolinium contrast   Gadolinium   -   -   -   1件:
13 
 1275   Standard ms dmts   -   -   -   -   1件:
13 
 1276   Standard of care   -   -   -   -   8件:
6,
13,
14,
49,
51,
64,
79,
85 
 1277   Standard treatment with a conventional drug   -   -   -   -   1件:
13 
 1278   Statin   -   -   -   -   1件:
13 
 1279   Stem cell transplantation   -   -   -   -   9件:
13,
19,
20,
46,
65,
90,
164,
234,
326 
 1280   Study drug   -   -   -   -   2件:
6,
13 
 1281   Sub0750mig   -   -   -   -   1件:
13 
 1282   Sub22282   -   -   -   -   1件:
13 
 1283   Sublingual tizanidine 12 mg   Tizanidine   D00776, D08611   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
13 
 1284   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 1285   Sunphenon   -   -   -   -   2件:
13,
113 
 1286   Sunphenon egcg   Epigallocatechin gallate   -   -   -   3件:
13,
17,
113 
 1287   Sunphenon egcg tm   Epigallocatechin gallate   -   -   -   1件:
13 
 1288   Suspension media   -   -   -   -   1件:
13 
 1289   Sustained-release oral dalfampridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 1290   Suvorexant   Suvorexant   D10082   2件: HCRTR1, HCRTR2   1件: Neuroactive ligand-receptor interaction   3件:
5,
6,
13 
 1291   T cell vaccination   -   -   -   -   1件:
13 
 1292   T-cell vaccination   -   -   -   -   1件:
13 
 1293   Taci-fc5   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
46,
49 
 1294   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 1295   Tanakan   Ginkgo biloba   -   -   -   1件:
13 
 1296   Tarenflurbil   Tarenflurbil   D09010   4件: APH1A, NCSTN, PSEN1, PSENEN   5件: Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Wnt signaling pathway   1件:
13 
 1297   Targretin   Bexarotene   D03106   3件: RXRA, RXRB, RXRG   15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease (NAFLD), Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer   1件:
13 
 1298   Taurine   Taurine   D00047   -   -   1件:
13 
 1299   Tauroursodeoxycholic acid   Tauroursodeoxycholic acid   -   -   -   4件:
2,
13,
93,
299 
 1300   Tcelna   -   -   -   -   1件:
13 
 1301   Tecfidera   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1302   Tecfidera (bg12)   -   -   -   -   1件:
13 
 1303   Tecfidera®   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1304   Tecfidera® 120 mg   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1305   Tecfidera® 120mg magensaftresistente hartkapseln   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1306   Tecfidera® 240 mg   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1307   Tecfidera® 240mg magensaftresistente hartkapseln   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1308   Tecifdera (dimethyl fumarate)   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 1309   Temsirolimus   Temsirolimus   D06068   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   4件:
13,
34,
89,
331 
 1310   Temsirolimus tablets   Temsirolimus   D06068   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   1件:
13 
 1311   Teriflunomide   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   2件:
13,
25 
 1312   Teriflunomide (hmr1726)   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 1313   Teriflunomide 14 mg   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 1314   Teriflunomide 14 mg oral tablet [aubagio]   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 1315   Teriflunomide hmr1726   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 1316   Teriflunomide orally   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 1317   Testosterone   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   7件:
1,
2,
3,
13,
78,
113,
265 
 1318   Testosterone undecanoate   Testosterone undecanoate   D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   1件:
13 
 1319   Tetanus diphtheria toxoid vaccine (td)   -   -   -   -   1件:
13 
 1320   Tetanus diphtheria toxoids vaccine   -   -   -   -   1件:
13 
 1321   Tetanus toxoid (tt) containing vaccine (td, tdap)   -   -   -   -   1件:
13 
 1322   Tetracycline   Tetracycline   D00201   -   -   4件:
13,
46,
53,
97 
 1323   Tetracycline - statin - antimycotic   Tetracycline   D00201   -   -   1件:
13 
 1324   Tetrahydrocannabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   2件:
13,
298 
 1325   Tg-1101   -   -   -   -   1件:
13 
 1326   Thiamine   Thiamine   D08580   -   -   2件:
13,
265 
 1327   Thioplex   -   -   -   -   1件:
13 
 1328   Thiotepa   Thiotepa   D00583   -   -   11件:
13,
19,
20,
28,
51,
60,
65,
85,
96,
164,
284 
 1329   Thymoglobuline   -   -   -   -   4件:
13,
36,
51,
65 
 1330   Tissue selective estrogen complex   -   -   -   -   1件:
13 
 1331   Tizanidine   Tizanidine   D00776, D08611   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
13 
 1332   Tizanidine (sublingual or oral)   Tizanidine   D00776, D08611   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
13 
 1333   Tizanidine hydrochloride capsule   Tizanidine   D00776, D08611   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
13 
 1334   Tmp001   -   -   -   -   1件:
13 
 1335   Tocilizumab   Tocilizumab   D02596   1件: IL6R   11件: Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease (NAFLD), PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 
 1336   Tocilizumab injection   Tocilizumab   D02596   1件: IL6R   11件: Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease (NAFLD), PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 1337   Tocopherol   Tocopherol   D02332   -   -   3件:
13,
49,
257 
 1338   Tolerogenic dendritic cells (toldc)   -   -   -   -   1件:
13 
 1339   Tolerogenic dendritic cells loaded with myelin peptides   -   -   -   -   1件:
13 
 1340   Tolperisone   Tolperisone   D08617   -   -   1件:
13 
 1341   Tolperisone hc1   Tolperisone   D08617   -   -   1件:
13 
 1342   Tolperisone hcl   Tolperisone   D08617   -   -   1件:
13 
 1343   Tolpersan   -   -   -   -   1件:
13 
 1344   Tolposan   -   -   -   -   1件:
13 
 1345   Topical preparation h arm   -   -   -   -   1件:
13 
 1346   Torvast*10cpr 10mg   -   -   -   -   1件:
13 
 1347   Tovaxin   -   -   -   -   1件:
13 
 1348   Tovaxin autologous t cell vaccine   -   -   -   -   1件:
13 
 1349   Tracleer   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
13,
51,
84,
85,
86,
88,
210,
211 
 1350   Trancopal dolo   -   -   -   -   1件:
13 
 1351   Treosulfan   Treosulfan   D07253   -   -   3件:
13,
19,
65 
 1352   Trichuris suis eggs   -   -   -   -   3件:
13,
96,
97 
 1353   Trichuris suis ova   -   -   -   -   4件:
13,
46,
96,
97 
 1354   Trichuris suis ova (eggs), embryonated, viable   -   -   -   -   1件:
13 
 1355   Trileptal   Oxcarbazepine   D00533   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
13 
 1356   Triomar™ (omega-3 fatty acids)   Omega-3 fatty acids   -   -   -   1件:
13 
 1357   Tro19622   Tro19622   -   -   -   3件:
2,
3,
13 
 1358   Tt vaccine   -   -   -   -   1件:
13 
 1359   Tv-5010   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 1360   Tv-5600   -   -   -   -   2件:
13,
96 
 1361   Tylenol pill   -   -   -   -   1件:
13 
 1362   Tysabri   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   3件:
13,
25,
63 
 1363   Tysabri 300 mg concentrate for solution for infusion   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 1364   Tysabri 300 mg solution à diluer pour perfusion   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 1365   Tysabri and avonex   -   -   -   -   1件:
13 
 1366   Tysabri ® (natalizumab)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 1367   Tysabri®   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 1368   Tysabri® (natalizumab)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 1369   Ublituximab   Ublituximab   D11243   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 1370   Ucb l059   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   1件:
13 
 1371   Ultra small particles of iron oxide (uspio)   Iron   -   -   -   1件:
13 
 1372   Ultrasmall particles of iron oxide   Iron   -   -   -   1件:
13 
 1373   Umbilical cord derived mesenchymal stem cells   -   -   -   -   1件:
13 
 1374   Umbilical cord mesenchymal stem cells   -   -   -   -   5件:
13,
46,
57,
97,
113 
 1375   Undifferentiated autologous mesenchymal stem cells   -   -   -   -   1件:
13 
 1376   Untreated to atorvastatin treatment   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 1377   Urbason 40 mg   -   -   -   -   1件:
13 
 1378   Urbason 40 mg comprimidos   -   -   -   -   1件:
13 
 1379   Urbason forte   -   -   -   -   1件:
13 
 1380   Urbason solubile forte 1000mg   -   -   -   -   1件:
13 
 1381   Urbason® solubile forte 1000 mg   -   -   -   -   1件:
13 
 1382   Urine samples   -   -   -   -   1件:
13 
 1383   Uvedose 100 000 ui   -   -   -   -   1件:
13 
 1384   Uvedose 100 000 ui, solution buvable en ampoule   -   -   -   -   1件:
13 
 1385   V08ca02   -   -   -   -   1件:
13 
 1386   V08ca09   -   -   -   -   1件:
13 
 1387   Vaginal estriol   Estriol   D00185, D01986   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
13 
 1388   Vardenafil   Vardenafil   D02731, D03260, D08668   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   3件:
13,
86,
299 
 1389   Vardenafil (hidrocloride)   Vardenafil   D02731, D03260, D08668   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   1件:
13 
 1390   Vardenafilo   Vardenafil   D02731, D03260, D08668   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   1件:
13 
 1391   Vardenafilo hidrocloruro   Vardenafil   D02731, D03260, D08668   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   1件:
13 
 1392   Vatelizumab   Vatelizumab   -   -   -   1件:
13 
 1393   Vay736   -   -   -   -   7件:
13,
35,
46,
49,
53,
85,
95 
 1394   Vb13s1   -   -   -   -   1件:
13 
 1395   Vb5s2   -   -   -   -   1件:
13 
 1396   Vb6s5   -   -   -   -   1件:
13 
 1397   Venlafaxin hexal   -   -   -   -   1件:
13 
 1398   Venlafaxine   Venlafaxine   D00821, D08670   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
46 
 1399   Venlafaxine hydrochloride   Venlafaxine   D00821, D08670   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
13,
46 
 1400   Verum arm receiving gilenya®   -   -   -   -   1件:
13 
 1401   Verum arm receiving vitamin d oil   Vitamin d   -   -   -   1件:
13 
 1402   Vigantol   -   -   -   -   2件:
13,
65 
 1403   Vigantol oel   -   -   -   -   3件:
13,
96,
97 
 1404   Vigantol oil   -   -   -   -   1件:
13 
 1405   Vigantol® öl 20.000 i.e./ml   -   -   -   -   1件:
13 
 1406   Vitamin a   Vitamin a   D00069, D06543   2件: RARA, RARB   8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer   3件:
13,
53,
90 
 1407   Vitamin d   Vitamin d   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 1408   Vitamin d3   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   11件:
6,
13,
20,
46,
49,
53,
60,
65,
96,
97,
299 
 1409   Vitamin e   Vitamin e   D02331   -   -   11件:
2,
6,
13,
20,
46,
90,
96,
97,
206,
299,
317 
 1410   Vitamin e/selenium   Vitamin e   D02331   -   -   1件:
13 
 1411   Vitamin k   Phylloquinone   D00148   -   -   3件:
13,
46,
96 
 1412   Vitamina d3 kern pharma solución oleosa   -   -   -   -   1件:
13 
 1413   Vsn16r   -   -   -   -   1件:
13 
 1414   Vsn16r 100mg   -   -   -   -   1件:
13 
 1415   Vx15/2503   Pepinemab   D11469   1件: SEMA4D   1件: Axon guidance   2件:
8,
13 
 1416   Warfarin   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 1417   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 1418   Way-130799   -   -   -   -   1件:
13 
 1419   Xbd173   -   -   -   -   1件:
13 
 1420   Xcel-mc-alpha   -   -   -   -   1件:
13 
 1421   Xeomin   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   7件:
5,
6,
7,
13,
15,
17,
113 
 1422   Zenapax   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 1423   Zk 157046   -   -   -   -   1件:
13 
 1424   Zol446h   -   -   -   -   1件:
13 
 1425   Zoledronic acid   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   9件:
6,
13,
46,
93,
95,
96,
274,
299,
333 
 1426   Zoledronic acid monohydrate   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 

先頭へ